Final Report Philippines - Amazon S3s3.amazonaws.com/zanran_storage/ leading causes of morbidity,...

SOUTH-SOUTH TRADE PROMOTION PROGRAMME

PHILIPPINES

SUPPLY AND DEMAND SURVEY ON PHARMACEUTICALS AND NATURAL PRODUCTS

July 2005

Supply and demand survey on pharmaceuticals and natural products – Philippines

- ii -

The designations employed and the presentation of the material in this document do not imply the expression of any opinion whatsoever on the part of the International Trade Centre (ITC) concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. While every effort has been made to verify the information contained in this document, ITC cannot accept any responsibility for any errors that it may contain.

This report has not been formally edited by the International Trade Centre (ITC).


- iii -

Table of contents

Page I. INTRODUCTION 1 A. Product coverage 1 B. Objectives of the demand survey 2 C. Methodology 2 II. SUMMARY OF CONCLUSIONS AND RECOMMENDATIONS 3 III. MAIN REPORT 8 A. Market size 8 B. RP’s distribution system 13 C. Market prospects 14 D. Regulatory environment 16 E. Useful addresses 21


- iv -

Page List of tables 1. Country’s health expenditure 2000 - 2002 92. Country’s health expenditure Per Capita 1993-2002 93. Governments fiscal allocation for health 2001-2002 94. 2000 and 2001 regional distribution of pharmaceutical establishments 115. Consumer profile 146. Health and vital statistics 157. Ten leading causes of morbidity, number and crude rates – 2001-2002 158. Mortality: Ten leading causes, number and crude rates and percent of total

deaths – 1999 and 2000 (Crude death rate per 100,000 population) 16

Annexes I. Product coverage for pharmaceutical products 25II. Product coverage for natural/herbal products 31III. Philippine imports of pharmaceutical products (2000-2004) 35IV. Philippine supplying countries of pharmaceutical products (2000-2004) 45V. Philippine imports of natural products (2000-2004) 49VI Philippine supplying countries of natural products (2000-2004) 55VII. Philippine exports of pharmaceutical products (2000-2004) 57VIII. Philippine exports markets of pharmaceutical products (2000-2004) 61IX. Philippine exports of natural products (2000-2004) 65X. Philippine exports markets of natural products (2000-2004) 71XI. Directory of thePhilippine Chamber of the Pharmaceutical Industry, Inc. 73XII. Directory of the Pharmaceutical and Healthcare Association of the

Philippines 85

XIII. Enterprise/product profile forms 93


- v -

NOTES The following abbreviations are used: BFAD Bureau of Food and Drug

BOI Board of Investment

BTRCP Bureau of Trade Regulation and Consumer Protection

CHIP, Inc. Chamber of Herbal Industries of the Philippines

ITC International Trade Centre

ITH Income Tax Holiday

LDA Developed Areas

OFW Overseas Filipino Workers

OTCs Over-The-Counter Drugs

PCPI Philippine Chamber of Pharmaceutical Industry

PHAP Pharmaceutical & Healthcare Association of the Philippines, Inc.

PITAHC Philippine Institute of Traditional and Alternative Health Care

PITC Philippine International Trading Corporation

PNDF Philippine National Drug Formulary

R&D Research and Development

USP-NF United States Pharmacopoeia / National Formulary


- 1 -

I. INTRODUCTION

The Philippine pharmaceutical industry is one of the vital sectors in the economy. As in all other economies, there should always be an ample supply chain of drugs and medicines made available to consumers in good quality and at reasonable and affordable prices. Through this, lives can be made better or even saved.

The industry is engaged in the manufacture, distribution and wholesale and retail sales of medicines and pharmaceutical specialties. The industry produces all forms of medicines and vaccines as, but not limited to, tablets, capsules, powders/suspension, liquids, creams/ointments, fine liquid and suppositories.

In the Philippine pharmaceutical industry, basic research in terms of extracting and producing raw materials and chemicals from local sources is not present. While almost 90% of all drugs sold are locally produced, the pharmaceuticals companies are mainly compounders, formulators and packagers. Their establishments are engaged in the importation, repacking, marketing and distribution of proprietary medicines and preparations.

As such investments along this activity are needed and being encouraged. As a support, the 2004 Investments Priority Projects of the Board of Investments (BOI), the manufacture of essential drugs including herbal medicines and supplements, food supplements limited to the manufacture of Vitamin A, iron and iodine and active substances of these drug has been included. This means investments in these activities will enjoy incentive package under the BOI guidelines.

A. Product coverage This demand survey covers all pharmaceutical import and export products (including active ingredients, starting materials and formulations) classified under the heading 54 of the Philippine Standard Classification Code and all import and export of natural products (including herbal medicines). The complete product coverage is in Annex I for pharmaceutical products and Annex II for natural and herbal products. Industry products and product classification

Products of the industry include all forms of medicines and vaccines that are useful in the identification (diagnostic), prevention (prophylactic) and treatment (therapeutic) of illness or the mitigation of disease symptoms. The following are the classification of drug products: • Therapeutic class – the more common therapeutic categories are analgesics, antacids,

antirheumatics, antibiotics, antidiarrheals, cardio-vascular preparations, cold/cough preparations, dermatological preparations, vitamins/minerals and hypertensives.

• Method of dispensing – drug products are classified as either ethical (promoted only to medical professionals and can be bought and sold only upon physician’s prescription) or proprietary (freely dispensed to the public and promoted over-the-counter).


- 2 -

• Dosage form – refers to the final form of a drug when it reaches the user. Examples are syrups,

injectibles, ointments, capsules, pills, tablets, powders, lozenges, solutions, suspensions, mixtures, tinctures, elixirs, extracts, fluid extracts, emulsions, lotions, sprays, aerosols and suppositories.

• Dosage strength – maybe purchased in various dosage strengths with the specific needs of the patients.

• Sources of basic raw materials – maybe classified as synthetic-based, plant-derived, animal-derived, vaccines and antibiotics and related fermented medicinal products.

B. Objectives of the demand survey

The survey is intended to pursue the following objectives:

• To give an overview of the Philippine pharmaceutical and natural products market by presenting the import profiles vis-à-vis supply capabilities of the local industries.

• To identify products under these sectors with high import potentials with sources of imports.

• To identify companies which could be targeted as potential importers/buyers.

• To identify companies which could targeted as potential suppliers especially in the natural / herbal sector.

C. Methodology

In preparing this survey the methodology utilized is as follows:

1. Desk research on: • Qualitative industry data using past studies and existing reports.

• Statistical data on Philippine imports of pharmaceutical and natural products for the last five (5) years.

• Statistical data on Philippine exports of pharmaceutical and natural products for the last five (5) years.

• Existing data of the National Statistics Office, Bureau of Food and Drugs, Department of Health, Bureau of Import Services, Board of Investments, and Bureau of Export Trade Promotion, all of the Department of Trade and Industry.

2. Field Research: • Interviews with industry players and industry experts

• Updating of companies contact information by telephone


- 3 -

II. SUMMARY OF CONCLUSIONS AND RECOMMENDATIONS

The Philippine pharmaceutical industry cannot be considered a true drug industry since basic research in terms of extracting and producing raw materials and chemicals from local sources is absent. Most local drug firms are thus confined to: importing raw materials and finished goods in bulk, formulating and processing these into various dosage forms, packaging finished products and distributing drugs to drugstores, physicians, hospitals and other retailers.

Basic drug chemicals are not manufactured locally and about 80% to 90% of the raw materials of the industry is imported, a situation which has persisted for the last few decades. Only minor components such as sugar, flour, cornstarch, alcohol, glucose and glycerin are locally produced. Aside from medicinal products, there are other imports, such as packaging materials, used by the drug industry, which have added to high import costs. Imported packaging materials include specialized items such as aluminum tubes and vial caps, glass vials, rubber droppers, intravenous solution bottles, and ampoules. Only packaging materials such as bottle caps, foils and blister foils are produced locally. In view of this situation, prospective investors are being encouraged in the aforementioned areas to enable the industry to be self-sufficient. Under the government’s 2004 Investments Priorities Plan (IPP), firms engaged in the manufacture of essential drugs (including herbal medicine and supplements) listed in the current Philippine National Drug Formulary (PNDF) and active substances of drugs are qualified to avail of fiscal and non-fiscal incentives as follows: 1. Fiscal incentives

• Income Tax Holiday (ITH) – a BOI-registered enterprise shall be exempt from the payment of

income taxes reckoned from the scheduled start of commercial operations as follows:

- New projects with pioneer status six (6) years - New projects with non-pioneer status four (4) years - Expansion projects three (3) years - New/expansion projects in Less six (6) years - Developed Areas (LDA), regardless of status

• Tax deduction for labor expense;

• Exemption from wharfage dues and export tax, duty, import and fees;

• Tax credit on raw materials and supplies. 2. Non-fiscal incentives

• Employment of foreign nationals;

• Simplification of custom procedures;

• Importation of consigned equipment; and

• Operation of bonded manufacturing/trading warehouse.


- 4 -

The Philippine pharmaceutical industry is controlled by a few transnationals, that 68% of the pharmaceutical market belongs to these foreign companies with the remaining 32% shared by Filipino enterprises with foreign investors. The size of the local pharmaceutical market could be measured by sales to trade outlets. In 2004, sales to trade outlets reached Php 80 billion or US$ 1.45 billion and the local market posted an average of 10% annual growth. To better understand the demand of pharmaceuticals, it is necessary to study the interplay between the pharmaceutical industry and its market. From the viewpoint of the industry, sales are determined by the following factors:

• The economy’s performance in terms of Gross National Product and purchasing power, and the

resultant family and institutional budgets made available for medical care, including pharmaceuticals;

• The size of the population and its rate of growth, as well as disease incidence which determine requirements for drug therapy;

• The government’s priorities and fiscal allocations for health, which define the level of pharmaceutical sales to the public sector.

From the viewpoint of the market, the nature of the demands differ among the proprietary and ethical segments:

• Proprietary drugs are similar to consumer items in terms of the dynamics of demand. End-users

suffering from ailments not requiring professional medical care recognize their condition (e.g. cough or cold), then purchase the proprietary products deemed most appropriate.

• The demand for prescription medicines is markedly different as it is not end-users but medical professionals who decide on the choice of drug therapy. To comply with the Generic Act of 1988, the physician provides the patient with a prescription containing a drug’s generic name and if desired, a recommended brand name. The pharmacist must dispense according to the physician’s prescription with regard to generic name. The patient, is however, free to choose among various brand names with the same generic name or active ingredient.

The Generics Act of 1988, an act to promote, require and ensure the production of an adequate supply, distribution, use and acceptance of drugs and medicines identified by their generic names, exerts a competitive influence between higher-priced branded drugs and lower-priced generic products with the aim of lowering drug prices. However, there is still no marked evidence of increased market share of generic drugs. Its share has constantly been placed at 8% notwithstanding the 10% average growth of the total pharmaceutical market. The main reason cited is the perception that lower prices may mean lower efficacy.


- 5 -

The Philippine International Trading Corporation (PITC), the trading arm of the government is a potential buyer. PITC is presently importing mainly from India, pharmaceutical products under the following therapeutic categories:

- Anti-bacterials - Anti-hypertensives - Non-steroidal anti-inflammatory drugs - Oral hypoglycemic/anti-diabetes agents - Anti-anginal agents - Anti-cholesterol agents - Bronchodilators - Anti-diarrheals - Anti-psychotics - Anti-epileptics

The pharmaceutical products are for most common ailments and diseases in the country. The prime consideration is lower cost. Competition in the drug market is intense and dynamic and this is best seen in the large number of competitors carrying various brand names and product lines. Prices of pharmaceutical products in the Philippines are generally higher by as much as ten (10) times, higher than in other Asian countries next to Japan. A significant factor contributing to the generally high drug prices is the import-dependent nature of the industry. Another factor is due to industry’s dependence on marketing, advertising and promotions as tools to ensure steady sales. Suppliers wishing to enter the Philippine market need to be able to prove quality at competitive prices to gain considerable success. The easiest and fastest way to penetrate the market is through acquiring a local partner who is already active in the industry. This partner has familiarity in handling all aspects of the business. The Directory of Philippine Chamber of Pharmaceutical Industry presented somewhere in the report would be useful in finding local partners when necessary. Mercury Drug Corporation is the largest pharmaceutical chain in the Philippines with about half or 50% of the overall pharmacy business. Prospective sellers should directly contact the company if interested to offer their products. The drug store could be contacted at this address:

Mercury Ave., cor E. Rodriguez Jr. Bagumbayan 1110 Quezon City Telephone No. : (632) 911.5071- 87 Fax No. : (632) 911.6673 Email address : [email protected] Website : www.mercurydrug.com

Since the country is an archipelago, it is uneconomical and inefficient for most pharmaceutical companies to distribute their products. Only a limited number of companies have their own distribution network, the rest avails of the service of the professional distributors. The pharmaceutical industry is profitable since there is very little price elasticity associated with price increases. A patient will not change the demand for a product with a small change in price when there are no close or available substitutes.


- 6 -

The long-term outlook is promising since demand for medicines and drugs is interdependent on the demographics of the country’s population. The growth of the population (81.1 million in 2003) at an annual average of 2.36% will surely cause an increased demand for drugs, along with the prevalence of communicable and infectious diseases and the rising incidence of degenerative diseases. There is an emerging local market for herbal medicines/ food supplements. Initial estimate from the industry players of the local market size is placed at US$ 40 million. The market is expected to grow dramatically in the coming years. People take herbal medicines for a number of reasons: faith in tradition, fear of artificial chemicals and attraction to anything that is billed as natural. At present, imported herbal supplements proliferated and sold at mostly high prices in health shops.

Reported local sales from herbal are estimated to be from PhP 17 million in 2000 to PhP 46 million in 2004. Annual average sales growth was from 30% to 70%. 1

The factors which are expected to contribute to the dramatic growth of the natural / herbal remedies are: • The increase in ageing population, trend towards self-medication, emergence of unknown

diseases and allergies due to widespread use of synthetic drugs and biotech products; increasing health consciousness of the population.

• The rising health costs and more focus on disease prevention rather than cure.

• The growing healthy lifestyle and the consumer demand for all natural products as a way of life.

• The growing consciousness for environment-friendly products. The most common and lately most demanded herbal medicine/supplement product which is produced locally is Ampalaya (Momordica Charantia) which the current sales is estimated at PhP5 million a day or translated to PhP 1.8 billion a year. This is attributed to its effectiveness for lowering blood sugar. Some ampalaya products which are mixed with other herbals are sold in capsules (crude extracts) and tea.

The other most common herbal personal care product is the Papaya ( Carica Papaya) based skin whitening soap which is being sold by different companies. The skin whitening soap category is worth at least PhP2 Billion a year and Filipinos buy as many as 200 million pieces a year. Again this is attributed to the effectiveness of the herbal products and partly since many Filipinos wanted to look fairer or white.

The Philippines has the potential to develop into one of the world’s largest growers of medicinal plants, given the country’s rich biodiversity and long tradition of use and intimate knowledge of herbal medicine. Five (5) percent of the world’s plant species can be found in the country. There are 13,500 plant species where 3,500 species are endemic. Around 1,500 were identified as medicinal plants. 850 medicinal plants were discussed in a book, “Medicinal Plants of the Philippines by 1 Figures were given by industry players


- 7 -

Dr. Eduardo Quisumbing (reprinted in 1978) and more than 200 medicinal plants with identified phytochemical in a book, “Philippines Medicinal Plants in Common Use: Their Phytochemistry and Pharmacology (Michael L. Tan / AKAP 1980) Only 120 medicinal plants have been scientifically validated for safety and efficacy of which 10 medicinal plants have been promoted by the Department of Health. The ten (10) are as follows:

• Lagundi (Vetex Negundo) – for asthma, coughs and colds; • Yerba Buena (Mentha Cordifolia) for body aches; • Sambong (Blumea Balsamifera) for dissolving urinary tract stones; • Tsaang Gubat (Ehnetia Microphylla) for stomach aches and diarrhea; • Niyug-niyogan (Qusiqualis Indica) – ascaris antihelminthic; • Bayabas (Psidium Guajava) – astringent; • Akapulko )Cassia Alata) – antifungal; • Ulasimang Bato (Peperonia Pellucida) for gout and lowering blood uric acid; • Bawang (Allium Sativa) – for lowering blood cholesterol; • Ampalaya (Momordica Charantia) – for lowering blood sugar.

Of these ten (10), only 4 are available in commercial formulation namely Lagundi, Sambong, Akapulko and Ampalaya. Two medicinal plants Tsaang Gubat and Yerba Buena have also received regulatory approval. The absence of the technology is a hindrance to the export potential of well-researched and proven herbal medicines. Research and development (R&D) has not caught up with the pace that the local pharmaceutical industry needs. Governments’ support to R&D is almost nil. The natural and herbal products are exported to countries with large concentration of Overseas Filipino Workers (OFW) through regular channels. The products have not reached the mainstream markets for the simple reason that promotion of the products has been limited to the domestic market.


- 8 -

III. MAIN REPORT

A. Market size

1. Domestic industry The Philippine pharmaceutical market as indicated by sales to trade outlets amounted to Php 80 billion or approximately US$ 1.45 billion in 2004. The local market registered an estimated annual growth of 10% in sales. However, due to the country’s high poverty threshold coupled with escalating population growth of about 2.4 percent annually and the meager annual health budget, placed the life saving commodity beyond the reach of many Filipinos because of its high cost and inequitable distribution. To address the heavy burden of high medicine prices on the Filipino consumers, the Philippine government under President Gloria Macapagal-Arroyo has directed the implementation of a program that will improve public access to quality healthcare. The program is called, Presyong Tama, Gamot Pampamilya (Right Price for Family Medicines) Program. The program involves the importation of widely recognized, off patent branded medicines, which are usually prescribed for the most common ailments and diseases. The medicines shall be made available to Filipino consumers at very affordable prices. Studies showed that prices of medicines in the Philippines are as much as ten (10) times higher that in other Asian countries next only to Japan. When the program began in 2000, there were seven (7) brands available in the country’s Department of Health retained hospitals nationwide. Today, this range has been expanded to a total of 25 brands from the following therapeutic categories: antibacterials, anti-hypertensives, non-steroidal, anti-inflammatory drugs, oral hypoglycemic/ anti-diabetes agents, anti-anginal agents, anti-cholesterol agents, bronchodilators, anti-motility agents/ anti-diarrheals, anti-psychoticsand anti-epileptics. Medicines sold are from 27% to 87% cheaper compared to those sold in local drug stores, yet these are not subsidized prices.

Medicines are sourced only from original manufacturers/multinational subsidiaries or authorized licensees and are of the same quality and efficacy as the higher-priced counterparts sold in local drugstores.

The importation of these medicines is made by the Philippine International Trading Corporation, a government trading company. 2. Apparent consumption The tables below will provide the reader an estimation of past and future demands for pharmaceutical products.


- 9 -

Table 1: Country’s health expenditure , 2000 to 2002

STATISTICS 2000 2001 2002 Total Health Expenditure (in billion pesos, at current prices) 114.9 116.6 115.4

Health Expenditure Growth Rate (%) at current prices 9.6 1.5 (1.0)

Total Health Expenditure (in billion pesos, at 1985 prices) 34.9 33.4 32.0

Health Expenditure Growth Rate (%) at 1985 prices 5.0 (4.3) (4.0)

Source : National Statistical Coordination Board Table 2: Country’s health expenditure Per Capita 1993-2002

Source : National Statistical Coordination Board Table 3. Governments fiscal allocation for health 2001-2002

Source of Funds Amount (in billion pesos) Growth Rate (in percent)

2001 2002 Government 42.2 34.6 (18.2) National 20.0 16.7 (16.3) Local 22.3 17.8 (19.9) Social Insurance 9.3 10.6 14.2 Medicare 9.0 10.3 14.6 Employee’s Compensation 0.3 0.3 1.9 Private Sources 63.6 68.6 7.9 Out-of-pocket 51.1 54.8 7.2 Private Insurance 2.9 3.4 15.7 HMOs 3.7 4.2 14.0 Employer- Based Plans 4.5 4.8 6.2 Private Schools 1.4 1.5 9.0 Others 1.5 1.7 10.0 ALL SOURCES 116.6 115.4 (1.0) Source : National Statistical Coordination Board

STATISTICS 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 Average Annual Growth

Rate

Health Expenditure Per Capita (in pesos at current prices)

725 817 954 1,089 1,217 1,308 1,449 1,486 1,484 1,435 8.1

Health Expenditure Per Capita (in pesos at 1985 prices)

363 378 408 427 451 441 459 451 424 398 1.15


- 10 -

3. Industry players Industry players in the pharmaceutical industry are classified into two (2), to wit: (a) Drug establishments Companies engaged in the manufacture, importation, re-packing and distribution of drugs and medicines. • Manufacturers

- Technically, these are formulators, who formulate from imported active raw materials

according to a specific recipe

- They manufacture their own products.

• Toll Manufacturers

- Technically, these are formulators, they formulate from imported active raw materials according to a specific recipe.

- They manufacture for third party companies or traders.

• Traders

- They are registered owners of drug products.

- They supply the raw materials and packaging components and provide products’

monographs, quality control standards and procedures.

- They subcontract the manufacture of such products to licensed manufacturers.

• Importers

- Import raw materials, active ingredients and/or finished products for their own use for wholesale distribution to other pharmaceutical establishments and outlets.

• Distributors

- For a fee they distribute other companies’ products nationwide.

- They also act as agents of some small foreign companies.

(b) Drug outlets Drug stores, pharmacies, and other establishments that sell drugs and medicines at retail level or dispense medicines for direct use of consumers.


- 11 -

• Drugstores, Pharmacies, Boticas including Hospital Pharmacies – these are drug outlets where registered drugs, chemical products, active principles, proprietary medicines or pharmaceutical specialties and dental medicines, or veterinary preparations are compounded and/or dispensed.

• Retail Outlets for Non-prescription drugs – these includes non-traditional outlets such as

supermarket and stores, drug outlets where registered non-prescription or over-the-counter (OTC) drugs are sold in their original packages, bottle or containers or in small original containers.

4. Regional distribution of pharmaceutical establishments Table 4 below shows the number of companies registered by the Bureau of Food and Drugs (BFAD) and their regional distribution. Table 4. 2000 and 2001 regional distribution of pharmaceutical establishments

REGION 2000 DRUG ESTABLISHMENTS

2001 DRUG ESTABLISHMENTS

Drug

Manufacturers

Drug Traders

Drug

Manufacturers

Drug Traders

NCR 123 348 113 314 CAR 0 2 0 2 I. Ilocos Region 4 2 4 2 II. Central Valley 1 1 1 1 III. Central Luzon 17 7 19 7 IV. Southern Tagalog 34 24 35 24 V. Bicol Region 1 0 1 0 VI. Western Visayas 7 5 9 4 VII. Central Visayas 18 5 20 5 VIII. Eastern Visayas 2 0 2 0 IX. Western Mindanao 2 5 2 5 X. Northern Mindanao 3 1 3 2 XI. Southern Mindanao 10 0 10 0 XII. Central Minadanao 1 0 1 0 CARAGA 2 0 2 0

Total 225 400 222 366 The concentration of drug manufacturers was in Metro Manila with 51% of the 222 drug manufacturers registered in 2001. The concentration is higher among drug traders of which 86% was in Metro Manila from the 366 registered drug traders. 5. RP’s imports of pharmaceutical products Bulk of the importations of the pharmaceutical industry is mainly composed of medicinal and pharmaceutical products for retail sale. This composed more than 53% of the total importations. The rest of the importations are chemicals, semi-finished products and other raw materials for the manufacture of drugs and pharmaceuticals for all types of ailments and diseases.. Imports grew at 6.4% from the years 2000 to 2004. The country’s pharmaceutical imports totaled to US$ 325.4 million in 2000 and reached US$ 417.4 million in 2004. (Please refer to Annex III for details)


- 12 -

6. RP’s supplying countries of pharmaceutical products Major suppliers of pharmaceutical products in 2004 are Switzerland (12.2% share), Australia (11.6% share), France (10.1% share), Germany (9.6% share), Great Britain (8.8% share) and USA (5.4% share). These countries are the centers of medicinal research and manufacture and the home bases of multinational pharmaceutical firms operating in the country. (Please refer to IV for details) 7. RP’s imports of natural products Imports of natural products registered an average growth rate of 7.6% during the five-year period 2000 to 2004. Imports were valued at US$ 32.2 million in 2000 and grew to US$ 43.0 million in 2004. The biggest import was hydrogenated vegetable fats and other vegetable fats which accounted for 24.7% of the country’s total imports. This was followed by seaweeds and other algae (11.1%); liquorice saps (8.7%) and carageenan (8.6%). (Annex V gives more details) 8. RP’s supplying countries of natural products Major suppliers of natural products in 2004 were Malaysia which accounted for (21.6%); USA (20.4%), Indonesia (10.9%), Singapore (8.5%) and Denmark (7.1%). (Other supplying countries are presented in Annex VI)

9. RP’s Exports of pharmaceutical products The country’s exports of pharmaceutical products achieved a growth rate of 6.6% during the period 2000 to 2004. Exports in 2000 were valued at US$ 16.2 million and increased to US$ 20.78 million in 2004. Bulk of the pharmaceutical exports was composed mainly of medicines and pharmaceutical products for retail sale, which accounted for over 83.2% of the total exports in 2004. (Please refer to Annex VII)

10. RP’s export markets of pharmaceutical products Major export markets for the country’s pharmaceutical exports are Vietnam (accounting for 14%), Australia (13.2%), Myanmar (12%), Thailand (8.2%), and Malaysia (7.2%). Most of the markets are neighboring Asian countries. (Please refer to Annex VIII)

11. RP’s Exports of natural products Exports of natural products, on the other hand, posted an average growth rate of 6.7% over the period 2000 to 2004. Exports in 2000 totalled to US$557.5 million and increased to US$ 673.1 million in 2004. Exports were made up mostly of coconut/copra oil crude and refined that accounted for a combined 85.8%. Another important export is carrageenan and seaweeds for a combined 13.3%. (Please refer to Annex IX) 12. RP’s export markets of natural products These natural products were exported mostly to the USA that absorbed 33.9% of the country’s total exports. This was followed by The Netherlands (32.9%), Malaysia (7%), Japan (6.0%), and Korea (3.2%) (Please refer to Annex X for more details)


- 13 -

B. RP’s distribution system

The diagram below illustrates how the pharmaceutical products distribution system works. I. MULTINATIONAL COMPANIES (MNC)

II NATIONAL COMPANIES (NC)

II IMPORTERS OF FINISHED PRODUCTS Distribution network of natural / Herbal products. • Natural / Herbal companies distribute their products through finding partners, exclusive

distributorships or otherwise

• Some companies distribute products directly to drugstores, supermarkets/groceries

MKTG PROMO

Mother companies /Foreign Suppliers oraw materials

Domestic Formulators: own ortoll formulators

Marketing Dept of companies w/ formulation facilities

Drug Dept Trader: Companies w/o formulation facilities

Third Party Distribution

Drugstores Hospitals

Clinics MD’s

CONSUMERS

Foreign Suppliers oraw materials

Domestic Formulators: own products toll formulator

Marketing Dept of companies w/ formulation facilities

Drug Dept Trader: Companies w/o formulation facilities

Third Party Distribution

Drugstores Hospitals

Clinics MD’s

CONSUMERS

Own Distribution

Suppliers MNC: Mother Companies

Domestic Companies 1. MNC: 2. NC

1. MNC Scheme

2. NC Scheme

Distribution System of Pharmaceutical Products


- 14 -

• Some companies distribute products directly through their own shops/outlets

• In terms of market reach, companies distribute on a national and regional level as well

C. Market prospects 1. Consumer profile (Table 5) INCOME AND EXPENDITURE (At current prices) 2003

2000

1997

1994

Annual average family income (PhP) 148,616 144,039 123,168 83,161Annual average family expenditure (PhP)

124,377 118,002 99,537 67,661

Annual average family saving (PhP) 24,239 26,037 23,61 15,500 POPULATION

20052

2000

1995

1990

Total (estimation)78,000,000

76,504,077

68,616,536

60,703,206

Male -

38,524,266

37,979,811

30,538,285

Female -

37,979,811

34,032,366

30,164,921

0-14 years 36,6% 37.0% 38.4% 39.6%15-64 years 59,7% 59.2% 58.1% 57.0%65 years and over 3,7% 3.8% 3.5% 3.4%Sex ratio 101.5 101.4 101.6 101.2

Density (persons per square kilometer) 276 255 229 202Growth rate 2.3% 2.4% 2.3% 2.4%Average household size - 5.0 5.1 5.3

-

2015

2010

2005

Population projection (medium assumption)

- 102,822,358 93,938,917 85,236,913

Source: National Statistics Office 2. State of health Tables 6 to 8 provide information regarding the state of health of the Filipinos. This will serve as guide to determine the types and kinds of pharmaceutical/medicines with big potential.

2 Source: Data for 2005: CIA WorldFactBook 2005, UNDP Human Development Report 2004 (estimations)


- 15 -

Table 6. Health and vital statistics

2001 2000 1999 1998

Births 1,714,093 1,766,440 1,613,335 1,632,859 Male 891,312 918,243 840,528 853,304 Female 822,781 848,197 772,807 779,555

Marriages 559,162 577,387 551,445 549,265 Death 381,834 366,931 347,989 352,992

Male 225,879 217,404 207,610 210,592 Female 155,955 149,527 140,379 142,400

20053 2005 2004 2003 Crude birth rate (per thousand population) 25.31 24.09 24.63 25.16 Crude deathe rate (per thousand population) 5.47 5.60 5.66 5.72

Crude rate of natural increase (per thousand pop.)

- 18.49 18.97 19.45

2015 2015 2010 2005 Total fertility rate (number of children per woman)

3.2 2.96 3.18 3.41

Life expectancy at birth ( in years) Male 67.9 67.6 66.1 64.1

Female 71.9 73.1 71.6 70.1 Source: National Statistics Office Table 7. Ten Leading Causes of Morbidity, 2001-2002

Disease 2002 Disease 2001 1 Pneumonias 734,581 Diarrheas 845,5262 Diarrheas 726,310 Bronchitis/Bronchiolitis 694,8363 Bronchitis/Bronchiolitis 629,968 Pneumonias 652,5854 Influenza 484,388 Influenza 499,8875 Hypertension 304,690 Hypertension 318,5216 TB Respiratory 114,221 TB Respiratory 110,8417 Diseases of the Heart 52,237 Diseases of the Heart 47,0408 Malaria 39,994 Malaria 40,5439 Chicken pox 28,600 Measles 24,49410 Measles 24,639 Chicken pox 24,359

Source : Department of Health

3 Source: Data for 2005: CIA WorldFactBook 2005, UNDP Human Development Report 2004 (estimations)


- 16 -

Table 8. Mortality: Ten Leading Causes, number and rate/100,000 Population 1999 & 2000

2000 1999 Causes

Number Rate Number Rate

1. Diseases of the Heart 60,417 79.1 58,574 78.42. Diseases of the Vascular System 48,271 63.2 43,671 58.43. Malignant Neoplasms 36,414 47.7 34,238 45.84. Pneumonia 32,637 42.7 32,883 44.05. Accidents 32,355 42.4 30,026 40.26. Tuberculosis, All Forms 27,557 36.1 28,904 38.77. Chronic Obstructive Pulmonary Diseases and Allied Condition 15,904 20.8 15,163 20.38. Certain Conditions Originating in the Perinatal Period 15,098 19.8 12,800 17.19. Diabetes Mellitus 10,747 14.1 9,749 13.010. Nephritis, Nephrotic Syndrome and Nephrosis 7,963 10.4 7,544 10.1

Source: Department of Health

D. Regulatory environment 1. Product registration The Department of Health through its Bureau of Food and Drugs (BFAD) is the regulatory body that governs the industry to insure safe, effective and quality pharmaceutical drugs to the market. All establishments engaged in the manufacture, importation or distribution of drugs must apply for a License to Operate (LTO) issued by BFAD. Other specific requirements depending on the type of activity to be undertaken are summarized below:


- 17 -

CHECKLIST OF REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICAL PRODUCTS

TYPE OF APPLICATION REQUIREMENTS INITIAL RENEWAL

1. Letter of application and Accomplish Form No. 8 (Application for registration of Pharmaceutical Product)

2. Suggested Retail Price (as per AO#48-C s. 1999) 3. Copy of valid agreement between manufacturer and trader,

distributor / importer / exporter

4. Unit dose and batch formulation 5. Technical specifications of finished product 6. Certificate of analysis of active raw materials 7. Certificate of analysis of finished product 8. Technical specifications of finished product 9. Full description of the methods used, the facilities and controls in

the manufacture, processing and packaging of the product

10. Details of the assay and other test procedures for finished product including data analysis

11. Detailed report of stability studies to justify claimed shelf life (accelerated or long term) 3 batches

12. Representative sample in market or commercial presentation. 13. Unattached generic labeling materials, label, box, insert, blister /

strip oil

14. For imported product: Certificates of free sale from country of origin Government certificate attesting to the status of the manufacture as to competency, reliability of personnel and facilities Both should be authenticated by territorial Philippine consulate

15. For product in plastic container: 15.1 Studies done on the plastic to substantiate claim that product

is safe to use: Components of the plastic used Chemical Test Physical tests Biological tests (cell toxicity, tissue implantation, etc.)

for parenteral and ophthalmic preparations. 15.2 Methodology on how different tests were conducted and

include limits (results) of each test. 15.3 Empty plastic containers and closures

16. For New Drug (if applicable) Pre-clinical studies Clinical studies (Phase I, II and III) Protocol for monitored release.

17. Certificate of approval of PMS (if applicable) 18. Bioavailability / bioequivalence studies (for Rifampicin products) 19. Dissolution profile for drug product under List B (B Prime) 20. Copy of latest Certificate of Product Registration (CPR)


- 18 -

CHECKLIST OF REQUIREMENTS FOR DRUG DISTRIBUTOR

1. Accomplished Notarized Petition Form / Joint Affidavit of Undertaking 2. List of products identified by generic names and brand names, to be distributed 3. Reference Materials:

Philippine National Drug Formulary R.A. 3720 Foods, Drugs & Devices & Cosmetics Act R.A. 6675 Generics Act of 1988 and relevant implementing rules and regulations R.A. 5921, Pharmacy Law as amended and relevant implementing rules and regulations R.A. 8203, Special Law on Counterfeit Drugs and its implementing rules and regulations Any one of the following reference books: United States Pharmacopoeia / National Formulary (USP-NF) latest edition Remington’s Pharmaceutical Sciences (latest edition) Goodman & Gilman Pharmacological Basis of Therapeutics (latest edition)

4. Batch Distribution Record Book 5. Copies of Pharmcist’s Registration Certificate, PRC-ID, valid PRT, ID picture, Duties and

Responsibilities, Certificate of Attendance of owner/pharmacist to a BFAD seminar on Licensing of Drug Establishments and outlets

6. Location Plan / Floor Plan (Office & Storage Room) with dimensions Photocopies of the following: If Corporation, Registration with SEC and Articles of Incorporation or Partnership If Single Proprietorship, Certificate of Business Name Registration with the Bureau of Trade Regulation and Consumer Protection (BTRCP) Contract of Lease for the space of the office and storage if the applicant does not own the building If Importer:

Foreign Agency Agreement from each supplier duly authenticated by the Territorial Philippine Consulate

Certificate of Registration of manufacturer and its conformity with GMP from Health Authority (for finished products only)

If Wholesaler:

A Valid contract with BFAD licensed supplier / manufacturer Certificate that the products it sells are registered with BFAD LTO of manufacturer

If Exporter:

A valid contract with BFAD licensed supplier / manufacturer Certification that the product it sell are registered with BFAD LTO of manufacturer


- 19 -

2. Product labelling BFAD sets specific standards and requirements for pharmaceutical firms to comply in labeling their products in order to have a clear presentation of the products minus fraudulent and misleading representations. In all cases, the generic name shall be the prominently printed element on the label, defined as the one with the highest point size among the various printed elements in the label. Information must include • Generic name of a particular pharmaceutical must appear above its brand name on all packaging • Registered trade or brand name; • Duly registered trademark; • Duly registered business name; • Philippine address of the manufacturer, importer or repacker of the consumer product; • General make or active ingredients; • Net quantity of contents, in metric terms of weight, measure or numerical count; • Country of manufacture, if imported; and • Statement that the consumer product is manufactured, refilled or repacked under license from a

principal, if applicable. • Directions for use; • Warning toxicity;

3. Import duties

As of January 1, 2003, all pharmaceutical products except those under the headings 29.36 and 29.37 have tariff rates of 3% while the other have 5%.

4. Customs valuation

The Philippines has been implementing the transaction value method of customs valuation since year 2000.

5. Prohibited and regulated drugs

(a) Prohibited drugs

• Drugs and substances designed, intended or adapted for producing unlawful abortion;

• Any adulterated or misbranded drug in violation of the provisions of the “Food and Drugs Act”;

• Marijuana, opium, poppies, coca leaves, heroin or any other narcotics or synthetic drugs which are or may hereafter be declared habit-forming by the President of the Philippines, or any compound, manufactured salt, derivative or preparation thereof, except when imported by the government of the Philippines or any person duly authorized by the Dangerous Drugs Board, for medicinal purposes only;


- 20 -

(b) Regulated drugs

• Certain commodities require clearance/permits from appropriate government agencies prior to

importation into the Philippines. These commodity groups are:

- Acetic anhydride (Dangerous Drugs Board) - Penicillin/derivatives (BFAD)

6. Regulatory guidelines

There are certain laws and administrative orders which are in force relative to the pharmaceutical industry and there are as follows:

REPUBLIC ACTS

R.A. No. 3720

AN ACT TO ENSURE THE SAFETY AND PURITY OF FOODS, DRUGS, AND COSMETICS BEING MADE AVAILABLE TO THE PUBLIC BY CREATING THE FOOD AND DRUG ADMINISTRATION WHICH SHALL ADMINISTER AND ENFORCE THE LAWS PERTAINING THERETO.

R.A. No. 6675

AN ACT TO PROMOTE, REQUIRE AND ENSURE THE PRODUCTION OF AN ADEQUATE SUPPLY, DISTRIBUTION, USE AND ACCEPTANCE OF DRUGS AND MEDICINES IDENTIFIED BY THEIR GENERIC NAMES

R.A. No. 8203 AN ACT OF PROHIBITING COUNTERFEIT DRUGS, PROVIDING PENALTIES FOR VIOLATIONS AND APPROPRIATING FUNDS THEREFOR

ADMINISTRATIVE ORDERS

A.O. No. 99 s. 2000

BANNING AND WITHDRAWAL OF THE FIXED – DOSE – COMBINATION DRUG PRODUCT LORATADINE + PSEUDOEPHEDRINE (CLARINASE) FROM THE MARKET

A.O. No. 98 s. 2000 VOLUNTARY WITHDRAWAL OF ASTEMIZOLE (HISMANAL) FROM THE MARKET

A.O. No. 97 s. 2000 BANNING AWITHDRAWAL OF CISAPRIDE (PREPULSID) FROM THE MARKET

A.O. No. 85 s. 2000

REGISTRATION, REQUIREMENTS FOR A GOVERNMENT AGENCY IMPORTING A PHARMACEUTICAL PRODUCT WITH A REGISTERED COUNTERPART BRAND IN THE PHILIPPINES

A.O. No. 23-C s. 2000 POLICIES AND GUIDELINES ON OVER-THE-COUNTER (OTC) DRUG PRODUCTS

A.O. No. 41 s. 1991 GUIDELINES ON ADVERTISEMENT AND PROMOTIONS OF VETERINARY DRUGS AND PRODUCTS


- 21 -

A.O. No. 99 s. 1990

REQUIREMENTS FOR LABELLING MATERIALS OF CATEGORIES OF PHARMACEUTICAL PRODUCTS CONTAINING FOUR OR MORE ACTIVE INGREDIENTS OUTSIDE THE COVERAGE OF A.O. 85 S. 1990

A.O. No. 85 s. 1990

REQUIREMENTS FOR LABELLING MATERIALS OF CATEGORIES OF PHARMACEUTICAL PRODUCTS CONTAINING TWO OR MORE ACTIVE INGREDIENTS

A.O. No. 56 s. 1989 REVISED REGULATIONS FOR THE LICENSING OF DRUG ESTABLISHMENTS AND OUTLETS

A.O. No. 55 s. 1988 REQUIREMENTS FOR LABELLING MATERIALS OF PHARMACEUTICAL PRODUCTS

A.O. No. 99-A s. 1984 REGULATION PART C-11: LISTING OF LOCAL HERBAL AND/OR TRADITIONAL DRUGS

A.O. No. 42 s. 1982 REGULATION PART C-10: DRUGS REGISTRATION OF HEALTH AND/OR TRADITIONAL DRUGS BOTH LOCAL AND IMPORTED

E. Useful addresses 1. Department of Trade and Industry

Bureau of Export Trade Promotion 5-8th Floor, New Solid Bldg.,

357 Sen. Gil J. Puyat Avenue, Makati City, 1200 Contact Number/s : Phone: (63-2) 8990147 Fax : (63-2) 8904704 Board of Investments 5th Floor, Industry & Investments Bldg. 385 Sen. Gil J. Puyat Avenue, Makati City 1200 Contact Number/s : Phone : (63-2) 8953640-41, 8953657, 8976682 loc 248 Fax : (63-2) 8953512

Bureau of Import Services

3rd Floor, Oppen Bldg. 349 Sen. Gil J. Puyat Avenue, Makati City Contact Number/s : Phone : (63-2) 8964430 -31 Telefax : (63-2) 8964430


- 22 -

Center for International Trade Expositions and Missions Golden Shell Pavilion, Roxas Blvd. corner Sen. Gil J. Puyat Avenue, Pasay City 1300 Contact Number/s : Phone : (63-2) 8312201 to 09 Fax : (63-2) 8323965, 8340177 Email: [email protected]

2. Department of Health

San Lazaro Compound, Tayuman, Sta. Cruz, Manila Philippines 1003 Phone : (632) 743.8301 to 23 Fax : (632) 743.1829 Email : [email protected] Bureau of Food and Drugs Civic Drive, Filinvest Corporate City Alabang, Muntinlupa City Philippines 1781 Contact Number/s : Phone: (63-2) 807.0721 / 842.5606 Fax : 807-0751 Email : [email protected] Philippine Institute of Traditional and Alternative Health Care (PITAHC) Unit 2402 Atlanta Centre, 31 Annapolis Street, Greenhills San Juan, Metro Manila 1503 Contact Number/s : Phone : (63-2) 727.2113 Telefax : (63-2) 727.7621 / 727.6199 Email : [email protected]

3. Industry associations

Pharmaceutical & Healthcare Association of the Philippines, Inc. (PHAP) Unit-502 5/F One Corporate Plaza 845 Pasay Road, Makati City 5299 Contact Number/s : Phone: (63-2) 815.0325 / 816.7334/8167373 Fax : (63-2) 819.2702 Mr. Edwin Feist - President Mr. Leo P. Wassmer – Exec. VP & CEO Email: [email protected]


- 23 -

Philippine Chamber of Pharmaceutical Industry (PCPI) Rm. 404 Jovan Condo 600 Shaw Blvd., cor Samat Street Mandaluyong City 1552 Contact Number/s : Phone : (63-2) 535.4835 Email : [email protected] Mr. Michael dela Cruz - President Chamber of Herbal Industries of the Philippines (CHIP) 7 Saturn St., Pasig, Greenland Village Rosario, Pasig City Contact Number/s : Phone : (63-2) 641-4338/09177565423 Fax : (63-2) 641-9271 Mr. Wilfredo Tuanqui - President


- 24 -


- 25 -

ANNEX I

COVERAGE FOR PHARMACEUTICAL PRODUCTS

HDG. HS PSCC PRODUCT DESCRIPTION 29.36

Provitamins and vitamins, natural or reproduced by synthesis (including natural concentrates), derivatives thereof used primarily as vitamins, and intermixtures of the foregoing, whether or not in any solvent

29361000 5411100 provitamins, unmixed (NK) 29362100 5411200 vit a & their derivatives,unmixd (NK) 29362200 5411301 vit b1 & its derivatives,unmixed (NK) 29362300 5411302 vitamin b2 & its derivatives, unmixed (NK) 29362400 5411303 d-/dl-pantothenic acid(vitamin b3/b5) & its derivatives,

unmixed (NK) 29362500 5411304 vit b6 & its derivatives,unmixed (NK) 29362600 5411305 vit b12 & its derivatives,unmixd (NK) 29362700 5411400 vit c & its derivatives,unmixed (NK) 29362800 5411500 vit e & its derivatives,unmixed (NK) 29362900 5411600 oth vits & their derivtv;unmixed (NK) 29369000 5411700 intermixtures of provitamins & vitamins wtr/not in any solvent

(NK) 29.37

Hormones, natural or reproduces by synthesis; derivatives thereof, used primarily as hormones, other steriods used primarily as hormones

29371000 5415200 pituitary(anterior)/simlr hormones, & their derivtv, not as medicment (NK)

29372100 5415301 cortisone,hydrocortisone,prednisone & prednisolone,not as medicaments (NK)

29372200 5415302 halogenated derivtv of adrenal cortical hormones,not as medicaments (NK)

29372900 5415309 oth adrenal cortical homrones & their derivtv, not as medicaments (NK)

29379100 5415100 insulin & its salts, not put up as medicaments (NK) 29379200 5415901 oestrogens & progestogens, not put up as medicaments

(NK) 29379900 5415909 oth hormones & oth hormone derivtv; oth steroids as

hormone,not as medic (NK) 29.38 Glycosides, natural or reproduced by synthesis , and their

salts, ethers, esters and other derivatives


- 26 -

29381000 5416101

rutoside(rutin) & its derivtv, not put up as medicaments (NK) 29389000 5416109 oth glycosided,nat'l/reproduced by synthesis&their

dervtv,not as medic (NK) 29.39

Vegetable alkaloids, natural or reproduced by synthesis and their salts, ethers, esters and other derivatives

29391000 5414100 alkaloids of opium & derivtv; salts, not put up as medicaments (NK)

29392100 5414201 quinine & its salts, not put up as medicaments (NK) 29392900 5414209 oth alkaloids of cinchona & derivtv; salts, not put up as

medicaments (NK) 29393000 5414300 caffeine & its salts,not put up as medicaments (NK) 29394100 5414401 Ephedrine and its salts (NK) 29394900 5414409 other ephedrines and their salts, not put up as medicaments

(NK) 29395000 5414500 theo-/amino- phylline & their derivtv; salts, not put up as

medicaments (NK) 29396200 5414602 ergotamine (inn) and its salts (NK) 29396900 5414609 other alkaloids of rye ergot and their derivatives; salts

thereof, not put up as medicaments (NK) 29397000 5414700 nicotine & its salts, not put up as medicaments (NK) 29399000 5414909 oth veg alkaloids; derivtv of alkaloids nes, & their salts, nes

(NK) 29.41 Antibiotics

29411000 5413100 penicillins&derivtv w/ penicillanic acid stru; salts,not as medicmnt (NK)

29412000 5413200 streptomycins & their derivtv; salts, not put up as medicaments (NK)

29413000 5413301 terramycin; salts, not put up as medicaments (NK) 29413000 5413309 oth tetracyclines & their derivtv; salts, not put up as

medicaments (NK) 29414000 5413901 chloramphenicol&derivtv, chloromycetin; salts, not put up as

medicaments (NK) 29415000 5413902 erythromycin&derivtv, incldg ilotycin, erythrocin,salts,not as

medicmnt (NK) 29419000 5413903 bacitracin; salts, not put up as medicaments (NK) 29419000 5413904 neomycin;salts,not as medicmnt (NK) 29419000 5413905 antibiotics for veterinary use; salts, not put up as

medicaments (NK)


- 27 -

29419000 5413909

oth antibiotics, & salts, nes, not put up as medicaments (NK) 30.01

Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included

30011000 5416201 glands & oth organs, for organo-therapeutc uses,dried,powdered/not (NK)

30012000 5416202 xtract of glands/oth organs/their secretions for organo-therapeutc (NK)

30019000 5416203 heparin & its salts (NK) 30019000 5416209 oth human/animal subs preprd for therapeutic/prophylactic

uses (NK) 30.02

Human blood; animal blood preapred for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or ot obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products

30021000 5416301 antisera [, bulk] (NK) 30021000 5416303 blood globulins, serum globulins & hemoglobin (NK) 30021000 5416309

other blood fractions and modified immunological products, whether or not obtained by means of biote (NK)

30022000 5416311 Cholera, dysentery & typhoid vaccine, (bulk) NK 30022000 5416313 rabies vaccine [, bulk] (NK) 30022000 5416321 Poliomyelitis & staphylococci vaccines (bulk) NK 30022000 5416329 other vaccines for human medicine [, bulk] (NK) 30023000 5416341 veterinary vaccines against foot and mouth disease [, bulk]

(NK) 30023000 5416349 other veterinary vaccines [,bulk] (NK) 30029000 5416401 human blood (NK) 30029000 5416402 animal blood preprd for therapeutic, prophylactic/diagnostic

uses (NK) 30029000 5416405 toxins, cultures of micro-organisms (excluding yeasts) and

similar products [, bulk] (NK) 30029000 5416403 antitetanic serum [, bulk] (NK)

30.03

Medicaments (excluding goods of hdg 30.03, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale


- 28 -

30031000 5421101 medicmnt containing penicillin, not put in

doses(/form/packgs for retail (NK) 30031000 5421104 medicmnt contg Erythromycin, not put up in

doses/form/packgs for retail, (NK) 30031000 5421105 medicmnt w/ penicillin/derivtv,penicillanic acid stru,for

veterinary (NK) 30031000 5421109 oth medicmnt w/ penicillins/derivtv, w/ penicillanic acid stru,

etc (NK) 30032000 5421202 medicmnt contg chloramphenicol,not in doses/form/packg for

retail (NK) 30032000 5421203 medicmnt contg terramycin,not put up in

doses/forms/packings for retail (NK) 30032000 5421204 medicmnt contg oth antibiotics for vete rinary,not doses/form

for retail (NK) 30032000 5421209 medicmnt contg oth antibiotics (NK) 30033100 5422100 medicmnt contg insulin, not put up in doses/forms/packings

for retail (NK) 30033900 5422201 medicmnt w/ antidiabetic preptn, not in doses/packings for

retail (NK) 30033900 5422209 medicmnt w/ oth-hormone/prodct FO 54145, not in

doses/packg for retail (NK) 30034000 5423109 medicmnt w/ alkaloids & derivtv, nes, not in doses/packg for

retail (NK) 30039000 5429101 medicmnt contg sulfonamides & sulfonamide comp, in

doses/packg for retail (NK) 30039000 5429102 medicmnt contg enzymes, not put up in doses/forms/packg

for retail (NK) 30039000 5429107 medicmnt w/ analgesics & antipyretics, not in doses/packg

for retail (NK) 30039000 5429108 medicmnt w/ shcistosomiasis medicine, not in doses/packg

for retail (NK) 30039000 5429111 veterinary medicmnt, not in doses/form/ packg for retail,oth

thn 5429104 (NK) 30039000 5429119 oth medicmnt, nes, not put up in doses/forms/packings for

retail (NK) 30.04

Medicaments (excluding goods of hdg 30.03, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale

30041000 5421301 medicmnt contg penicillin, put up in doses/forms/packings for retail (NK)

5421302 medicmnt contg erythromycin/dihydrostrep-tomycin in doses/oth for retail (NK)


- 29 -

30041000 5421304 medicmnt contg erythromycin,put up in

doses/forms/packings for retail (NK) 30041000 5421305 medicmnt w/ penicillins/derivtv, etc, for retail sale, for

veterinary (NK) 30041000 5421309 oth medicmnt w/ penicillins/derivtv,etc in doses/form/packing

for retail (NK) 30042000 5421901 medicmnt contg bacitracin, put up in doses/forms/packings

for retail (NK) 30042000 5421902 medicmnt contg chloramphenicol, put up in

doses/forms/packg for retail (NK) 30042000 5421903 medicmnt contg terramycin, put up in doses/forms/packings

for retail (NK) 30042000 5421904 medicmnt w/ oth antibiotics for veterinary use,in doses/oth

for retail (NK) 30042000 5421909 medicmnt w/ oth antibiotics,nes, in doses/forms/packg for

retail (NK) 30043100 5422300 medicmnt contg insulin, put up in doses/forms/packings for

retail (NK) 30043200 5422400 medicmnt contg adrenal cortex hormones, in

doses/forms/packg for retail (NK) 30043900 5422900 medicmnt w/ oth-hormone/prodct of 5415, in

doses/forms/packgs for retail (NK) 30044000 5423201 medicmnt contg opium alkaloids,in doses forms/packings for

retail sale (NK) 30044000 5423202 medicmnt w/ alkaloids, of cinchona bark, in

doses/form/packing for retail (NK) 30044000 5423209 medicmnt w/ alkaloids&alkaloids derivtv ,in doses/form/packg

for retail (NK) 30045000 5429200 medicmnt w/ vit/oth prodct of 5411, in doses/forms/packings

for retail (NK) 30049010 5429314 specialized medicines for cancer, aids and other dreaded

diseases (NK) 30049020 5429316 closed sterile water system for inhalation, pharmaceutical

grade (usp, nf or bp) (NK) other 30049090 5429301 sulfonamides & sulfonamide comp, in doses/forms/packings

for retail (NK) 30049090 5429303 medicated candies,cough-syrups&drops,in

doses/forms/packings for retail (NK) 30049090 5429305 veterinary medicine for eradication of parasites, for retail sale

(NK) 30049090 5429306 veterinary medicmnt doses/forms/packg/ for retail sale, oth

thn 5429305 (NK)


- 30 -

30049090 5429307 anaesthetics, put up in measured doses/ forms/packings for

retail sale (NK) 30049090 5429308 glucose, preprd as medicmnt, put up in doses/forms packing

for retail sale (NK) 30049090 5429311 trypanocidal and antiluetic preptn, in doses/forms/packings

for retail (NK) 30049090 5429312 analgesics & antipyretics, put up in doses/forms/packings for

retail (NK) 30049090 5429315 water, medicinal, distilled, packed for retail (NK) 30049090 5429319 oth medicmnt w/ oth medicinal & pharmaceutical prodct,

nes, for retail sale (NK)


- 31 -

ANNEX II

COVERAGE FOR NATURAL/HERBAL PRODUCTS

HDG. HS PSCC PRODUCT DESCRIPTION

12.11

Plants and parts of plants (ncluding seeds and fruits), of a kind used primarily in perfumery, in pharmacy or for insecticidal, fungicidal or similar purposes, fresh or dried, whether or not cut, crushed or powdered.

12111000 2924100 liquorice roots (nk) 12112000 2924200 ginseng roots (nk) 12119000 2924901 eucalyptus leaves (nk) 12119000 2924902 cinchona bark (nk) 12119000 2924903 cedar powder (nk) 12119000 2924904 pyrethrum (nk)

12119000 2924909 other plants and parts of plants (including seeds and fruits) of a kind used primarily in perfumery, (nk)

121220 12122000 2929700 seaweeds and other algae (nk)

13.01 Lac, natural gums, resins, gum-resins and oleoresins (for example, balsams)

13011000 2922101 shellac (nk) 13011000 2922109 oth lac (nk) 13012000 2922200 gum arabic (nk) 13019000 2922901 resin, copal(almaciga) (nk) 13019000 2922902 gum, elemi (nk) 13019000 2922903 gum, tragacanth (nk) 13019000 2922904 gum, guar (nk) 13019000 2922905 resin, natural (nk) 13019000 2922906 incense & myrrh (nk) 13019000 2922909 oth nat gum,gum-resins & balsam (nk)

1302

Vegetable saps and extracts; pectic substances, pectinates and pectates, agar-agar and other mucilages and thickeners, whether or not modified, derived from vegetable products.

Vegetale saps and extracts 13021100 2929401 opium sacs & extracts 13021200 2929402 liquorice saps & extracts (nk) 13021300 2929403 extracts of hops (nk) 13021400 2929404 extracts of pyrethrum/roots of plants contg rotenone (nk) 13021900 2929409 oth vegetable saps & extracts (nk) 13022000 2929500 pectic substances, pectinates&pectates (nk) 13023100 2929601 agar-agar, whether or not modified (nk)

mucilages and thickeners, whether or not modified, derived from vegetable products

13023200 2929602 mucilages and thickeners derived from locust beans, locust bean seeds or guar seed, whether or not m (nk)


- 32 -

13023910 2929603 carrageenan (nk)

13023990 2929609 mucilages and thickeners derived from vegetable products, n.e.s., whether or not modified (nk)

15.08 Ground-nut oil and its fractions, whether or not refined, but not chemically modified

1508.1 4213100 groundnut(peanut) oil, crude (nk) 15089000 4213900 groundnut(peanut) oil, refined & its fractions (nk)

15.13 coconut (copra), palm kernel or babassu oil and fractions thereof, whether or not refined, but not chemically modified

15131100 4223100 coconut(copra)oil, crude (gk) 15131900 4223900 coconut(copra) oil, refined & its fractions (gk) 15132100 4224100 palm kernel/babassu oil, crude (nk) 15132900 4224900 palm kernel/babassu oil, refined and fractions thereof (nk)

15.15

Other fixed vegetable fats and oils (including jojoba oil) and their fractions, whether or not refined, but not chemically modified

15151100 4221100 linseed oil, crude (nk) 15151900 4221900 linseed oil, refined & its fractions (nk) 15152100 4216100 maize(corn) oil, crude (nk) 15152900 4216900 maize(corn) oil, refined & its fractions (nk) 15153000 4225000 castor oil & its fractions (nk)

15154000 4229100 tung oil and its fractions, whether or not refined, but not chemically modified (nk)

15155000 4218000 sesame(sesamum) oil & its fractions (nk)

15159000 4229902 jojoba oil and its fractions, whether or not refined, but not chemically modified (nk)

15159000 4229901 tobacco seed oil and its fractions, whether or not refined, but not chemically modified (nk)

15159000 4229903 oiticica oil and its fractions, [refined, solidified or hardened by mechanical means] whether or not (nk)

15159000 4229909 other fixed vegetable fats and oils, and their fractions, [crude, refined or fractionated, n.e.s.] w (nk)

1516

Animal or vegetable fats and oils and their fractions, partly or sholly hydrogenated, inter-esterified, re-esterified or elaidinised, whether or not refined, but not further prepared.

15161000 4312100 animal fats&oils&fractions,hydrogenated inter-/re-esterified/elaidinized (nk)

151620 Vegetable fats and oils and their fractions 15162010 4312201 hydrogenated vegetable fats in flakes (nk)

15162090 4312209 other vegetable fats and oils and their fraction partly or wholly hydrogenated (other than in flakes (nk)

1521

Vegetable waxes (other than triglycerides), bees wax, other insect waxws and spermaceti, whether or not refined or coloured


- 33 -

15211000 4314101 carnauba wax (nk) 15219000 4314109 oth veg waxes, wtr/not colored (nk) 15219000 4314201 beeswax (nk)

15219000 4314202 spermaceti, crude, pressed/refined, wtr/not colored (nk) 15219000 4314209 oth insect waxes, wtr/not refined/ colored (nk)

1804 18040000 724000 cocoa butter, fat/oil (nk)

3203 32030000

Coloring matter of vegetable or animal origin (including dyeing extracts but excluding animal black) whether or not chemically defined

32030000 5322201 natural indigo (nk) 32030000 5322202 annatto(achuete) (nk) 32030000 5322203 food color, of veg/animal origin (nk)

32030000 5322209 oth coloring matter of veg/animal origin & preptns based thereon (nk)

33.01

Essential oils (terpeneless or not) including corncretes and absolutes; resinoids; extracted oleoresins; concentrates of essential oilsin fats, in fixed oils, in waxes or the like, obtianed by enfleurage or maceration; terpenic by -productsof the deterpenation of essential oils, aqueous distillates and aqueous solutions of essential oils.

Essential oils of citrus fruit 33011100 5513121 bergamot oil (nk) 33011200 5513103 orange oil for mfr of medicine (nk) 33011200 5513113 orange oil oth for mfr of medicn (nk) 33011300 5513101 lemon oil for mfr of medicine (nk) 33011300 5513111 lemon oil oth for mfr of medcine (nk) 33011400 5513102 lime oil for mfr of medicine (nk) 33011400 5513112 lime oil oth for mfr of medicine (nk)

33011900 5513109 oth essetial oils of citrus fruits for manufacture of medicine (nk)

33011900 5513119 oth essential oils of citrus fruits oth for the manufacture of medicine (nk)

Essential oils other than those of citrus fruit 33012200 5513225 jasmin oil (nk) 33012300 5513226 lavender/lavandin oil (nk) 33012600 5513227 vetiver oil (nk)


- 34 -


- 35 -

ANNEX III

PHILIPPINE IMPORTS OF PHARMACEUTICAL PRODUCTS CIF VALUE IN US DOLLARS (2000 – 2004)

Supply and demand survey on pharm

aceuticals and natural products – Philippines

- 36 -

2004 2003 2002 2001 2000 HS PSCC Product Description Quantity Value %Share Quantity Value Quantity Value Quantity Value Quantity Value %Ave.

Growth Rate

TOTAL 417,356,623 100.00 390,334,843 361,632,590 336,369,863 325,404,975 6.43

1 30049090 5429319 oth medicmnt w/ oth medicinal & pharmaceutical prodct, nes, for retail sale (nk)

7,921,597 223,117,917 53.46 7,444,586 206,266,449 7,774,533 180,495,577 6,531,859 169,226,103 4,978,409 147,644,228 10.93

2 30042000 5421909 medicmnt w/ oth antibiotics,nes, in doses/forms/packg for retail (nk)

620,979 25,368,700 6.08 589,310 18,052,303 511,347 22,326,691 770,953 18,643,547 734,120 26,468,933 2.90

3 30049010 5429314 specialized medicines for cancer, aids and other dreaded diseases (nk)

997,952 19,683,791 4.72 1,864,760 14,084,703 1,431,446 15,006,763 1,155,274 12,283,700 2,118,082 12,477,922 13.56

4 30041000 5421309 oth medicmnt w/ penicillins/derivtv,etc in doses/form/packing for retail (nk)

1,015,640 16,531,014 3.96 822,519 14,061,646 339,872 7,308,250 196,727 3,706,821 238,789 4,369,032 47.99

5 30022000 5416329 other vaccines for human medicine [, bulk] (nk)

81,407 15,774,198 3.78 111,899 9,058,532 135,417 11,646,507 111,595 11,700,778 83,880 9,738,928 17.90

6 29419000 5413909 oth antibiotics, & salts, nes, not put up as medicaments (nk)

473,534 15,573,434 3.73 673,676 19,159,755 1,153,473 20,055,543 517,739 16,899,597 315,103 20,075,270 -5.09

7 30043900 5422900 medicmnt w/ oth-hormone/prodct of 5415, in doses/forms/packgs for retail (nk)

206,150 13,003,836 3.12 443,307 13,006,709 328,017 10,449,714 137,092 9,385,707 129,566 6,145,134 22.13

8 30023000 5416349 other veterinary vaccines [,bulk] (nk)

220,110 12,372,756 2.96 214,714 13,156,917 227,497 14,775,399 248,812 14,346,794 239,221 13,670,029 -2.24

9 29362700 5411400 vit c & its derivatives,unmixed (nk)

1,087,583 9,857,962 2.36 1,136,479 9,330,823 984,075 5,060,451 1,020,493 5,807,647 1,052,808 6,492,880 16.66

10 30039000 5429119 oth medicmnt, nes, not put up in doses/forms/packings for retail (nk)

1,738,458 6,448,501 1.55 1,177,107 6,237,711 1,046,909 6,339,203 2,087,824 6,390,282 582,549 5,752,770 3.02

11 30043200 5422400 medicmnt contg adrenal cortex hormones, in doses/forms/packg for retail (nk)

65,378 4,718,594 1.13 22,575 2,162,445 18,366 1,909,629 16,718 1,914,620 35,461 2,907,141 24.26



- 37 -

12 30045000 5429200 medicmnt w/ vit/oth prodct of

5411, in doses/forms/packings for retail (nk)

648,720 4,590,300 1.10 554,601 7,911,805 642,084 6,325,350 677,705 10,907,697 486,722 8,881,632 -9.03

13 29362800 5411500 vit e & its derivatives,unmixed (nk)

480,846 4,424,984 1.06 435,610 2,913,127 424,341 2,790,452 261,931 2,512,347 157,517 1,916,417 24.62

14 29411000 5413100 penicillins&derivtv w/ penicillanic acid stru; salts,not as medicmnt (nk)

202,038 3,967,616 0.95 100,009 2,812,505 103,622 2,360,374 131,283 2,837,266 647,175 4,213,226 2.69

15 30021000 5416309 other blood fractions and modified immunological products, whether or not obtained by means of biote (nk)

22,501 3,592,048 0.86 43,176 7,844,504 49,378 10,991,587 35,923 5,836,997 131,004 4,879,898 6.27

16 29362900 5411600 oth vits & their derivtv;unmixed (nk)

404,077 3,571,602 0.86 753,117 4,430,287 409,531 5,998,340 318,204 4,558,902 260,600 2,677,709 14.08

17 29415000 5413902 erythromycin&derivtv, incldg ilotycin, erythrocin,salts,not as medicmnt (nk)

19,153 3,185,753 0.76 25,740 2,687,986 30,196 1,947,960 23,892 3,084,316 25,610 4,128,819 -1.41

18 30032000 5421209 medicmnt contg oth antibiotics (nk)

64,942 3,040,841 0.73 47,047 1,369,802 36,790 2,253,766 29,919 1,059,370 64,174 1,663,118 39.81

19 29362100 5411200 vit a & their derivatives,unmixd (nk)

107,318 2,893,035 0.69 108,563 2,811,109 131,335 2,923,154 160,248 3,172,084 58,980 1,881,563 14.96

20 29369000 5411700 intermixtures of provitamins & vitamins wtr/not in any solvent (nk)

262,428 2,797,361 0.67 365,275 4,734,936 443,584 4,851,938 443,986 4,336,536 243,980 3,131,115 1.77

21 30043100 5422300 medicmnt contg insulin, put up in doses/forms/packings for retail (nk)

15,977 2,459,986 0.59 15,396 3,101,356 63,460 2,017,544 7,993 1,477,100 10,189 2,385,928 7.89

22 30049020 5429316 closed sterile water system for inhalation, pharmaceutical grade (usp, nf or bp) (nk)

1,467,019 2,427,990 0.58 30,167 403,306 19,870 188,160 10,128 112,869 356,330 9,363,407 146.07

23 29362400 5411303 d-/dl-pantothenic acid(vitamin b3/b5) & its derivatives, unmixed (nk)

200,544 1,941,464 0.47 129,055 1,329,698 199,955 1,876,007 109,719 1,441,445 1,599,277 1,473,829 11.21

24 29393000 5414300 caffeine & its salts,not put up as medicaments (nk)

244,857 1,777,253 0.43 281,470 1,957,388 240,314 1,757,687 246,776 1,850,621 164,335 1,308,946 9.63

25 29362200 5411301 vit b1 & its derivatives,unmixed (nk)

64,908 1,651,922 0.40 43,552 794,432 52,499 744,041 66,095 881,951 58,217 840,165 26.01

26 30029000 5416405 toxins, cultures of micro-organisms (excluding yeasts) and similar products [, bulk] (nk)

35,168 1,601,680 0.38 115,090 2,413,495 58,087 1,658,687 51,684 1,510,988 36,090 810,302 27.03



- 38 -

27 29413000 5413309 oth tetracyclines & their derivtv; salts, not put up as medicaments (nk)

173,997 1,073,121 0.26 490,820 1,444,269 448,578 982,664 659,644 1,706,081 173,698 1,024,117 11.37

28 29362300 5411302 vitamin b2 & its derivatives, unmixed (nk)

43,652 982,393 0.24 43,698 619,131 50,787 846,377 40,291 844,653 43,929 899,703 6.48

29 30031000 5421109 oth medicmnt w/ penicillins/derivtv, w/ penicillanic acid stru, etc (nk)

39,514 841,827 0.20 8,448 221,402 35,740 132,782 0 0 6,367 36,677 61.74

30 30033900 5422209 medicmnt w/ oth-hormone/prodct fo 54145 ,not in doses/packg for retail (nk)

47,330 739,621 0.18 55,885 1,196,525 31,806 684,375 7,768 182,445 25,370 355,676 65.76

31 29362600 5411305 vit b12 & its derivatives,unmixd (nk)

29,177 627,182 0.15 14,186 598,021 56,527 1,133,708 61,859 1,100,236 26,918 836,512 -1.95

32 29389000 5416109 oth glycosided,nat'l/reproduced by synthesis&their dervtv,not as medic (nk)

44,657 560,365 0.13 9,229 73,029 42,509 247,132 11,074 166,408 6,677 123,537 170.02

33 30023000 5416341 veterinary vaccines against foot and mouth disease [, bulk] (nk)

9,961 529,287 0.13 1,541 36,382 3,389 143,160 14,182 575,271 16,132 917,676 291.95

34 30049090 5429303 medicated candies,cough-syrups&drops,in doses/forms/packings for retail (nk)

107,960 498,105 0.12 132,421 519,660 42,824 232,492 143,605 538,023 115,409 776,488 7.97

35 29362500 5411304 vit b6 & its derivatives,unmixed (nk)

27,674 495,275 0.12 87,263 688,046 69,269 822,475 49,330 713,876 35,676 615,494 -3.29

36 29414000 5413901 chloramphenicol&derivtv, chloromycetin; salts, not put up as medicaments (nk)

28,200 473,179 0.11 20,567 349,833 19,505 335,266 85,815 638,849 127,901 839,583 -7.96

37 29399000 5414909 oth veg alkaloids; derivtv of alkaloids nes, & their salts, nes (nk)

38,170 377,797 0.09 42,299 358,525 23,040 336,754 28,224 500,878 7,275 455,341 -2.73

38 30044000 5423209 medicmnt w/ alkaloids&alkaloids derivtv ,in doses/form/packg for retail (nk)

25,625 362,408 0.09 96,429 1,747,771 106,867 1,321,232 45,535 997,326 18,217 1,892,106 -15.45

39 30012000 5416202 xtract of glands/oth organs/their secretions for organo-therapeutc (nk)

14,381 337,019 0.08 18,330 420,612 15,235 571,560 20,334 481,200 15,346 774,045 -16.33

40 30049090 5429306 veterinary medicmnt doses/forms/packg/ for retail sale, oth thn 5429305 (nk)

38,349 301,439 0.07 26,357 353,190 13,855 211,429 3,672 218,479 14,391 239,158 10.13

41 30042000 5421904 medicmnt w/ oth antibiotics for veterinary use,in doses/oth for retail (nk)

18,182 300,387 0.07 13,173 92,129 4,990 89,950 12,389 381,962 8,509 375,051 38.47



- 39 -

42 29372100 5415301 cortisone,hydrocortisone,prednisone & prednisolone,not as medicaments (nk)

763 294,009 0.07 1,179 141,635 1,462 165,059 6,844 442,622 446 329,227 16.28

43 29372200 5415302 halogenated derivtv of adrenal cortical hormones,not as medicaments (nk)

23 279,267 0.07 2,100 430,672 3,783 1,150,896 3,445 1,801,829 1,542 1,546,696 -29.34

44 30044000 5423201 medicmnt contg opium alkaloids,in doses forms/packings for retail sale (nk)

9,441 183,144 0.04 2,660 28,858 481 25,113 1,216 101,705 663 131,176 112.94

45 30039000 5429111 veterinary medicmnt, not in doses/form/ packg for retail,oth thn 5429104 (nk)

15,274 160,597 0.04 4,060 27,433 1,288 13,738 266 12,122 46,542 165,766 126.44

46 30032000 5421204 medicmnt contg oth antibiotics for vete rinary,not doses/form for retail (nk)

9,765 142,217 0.03 8,706 108,922 7,949 68,113 5,011 22,047 0 0 74.86

47 29372900 5415309 oth adrenal cortical homrones & their derivtv, not as medicaments (nk)

1,214 139,877 0.03 5 40,391 620 52,377 9,149 92,235 2,104 19,627 137.54

48 29419000 5413905 antibiotics for veterinary use; salts, not put up as medicaments (nk)

3,377 126,293 0.03 17,340 247,213 9,847 95,583 2,524 26,688 76,678 39,487 83.87

49 29412000 5413200 streptomycins & their derivtv; salts, not put up as medicaments (nk)

4,559 119,586 0.03 4,536 113,235 29,038 372,411 34,314 416,931 47,002 1,330,047 -35.83

50 29391000 5414100 alkaloids of opium & derivtv; salts, not put up as medicaments (nk)

31,673 106,621 0.03 180 17,839 1,205 56,500 90,664 62,211 10,685 39,318 119.58

51 29361000 5411100 provitamins, unmixed (nk) 54,637 89,672 0.02 3,640 27,849 6,965 196,344 66,155 539,547 45,449 286,438 40.23

52 30029000 5416402 animal blood preprd for therapeutic, prophylactic/diagnostic uses (nk)

20,960 79,280 0.02 68,937 358,041 25,394 115,032 7,518 219,284 48 791 6927.06

53 30049090 5429315 water, medicinal, distilled, packed for retail (nk)

15,731 74,547 0.02 23,902 75,607 0 0 40 39,423 272 36,323 -23.22

54 29419000 5413903 bacitracin; salts, not put up as medicaments (nk)

35,200 69,455 0.02 0 0 3,600 16,137 4,349 274,601 3 1,815 3708.85

55 30022000 5416311 cholera, dysentery and typhoid vaccine [, bulk] (nk)

230 62,989 0.02 0 0 0 0 1,888 187,704 58 2,362 1936.71

56 30019000 5416209 oth human/animal subs preprd for therapeutic/prophylactic uses (nk)

20,574 60,571 0.01 5,117 59,197 1,138 78,754 20,764 220,214 4,108 256,008 -25.18



- 40 -

57 30034000 5423109 medicmnt w/ alkaloids & derivtv, nes, not in doses/packg for retail (nk)

1,985 56,541 0.01 12,377 184,318 4,310 76,280 2,858 74,753 701 103,444 11.65

58 30041000 5421301 medicmnt contg penicillin, put up in doses/forms/packings for retail (nk)

9,273 48,680 0.01 107,778 6,451,562 59,858 5,254,943 67,723 4,261,282 52,747 2,975,706 -2.49

59 30042000 5421902 medicmnt contg chloramphenicol, put up in doses/forms/packg for retail (nk)

6,013 45,527 0.01 1,634 3,690 132 3,116 14,252 220,346 218 25,380 455.45

60 29392900 5414209 oth alkaloids of cinchona & derivtv; salts, not put up as medicaments (nk)

96,765 39,528 0.01 501 14,351 200 7,736 400 51,748 461 57,557 41.45

61 29395000 5414500 theo-/amino- phylline & their derivtv; salts, not put up as medicaments (nk)

3,400 38,123 0.01 2,753 39,615 152,925 200,072 3,182 216,542 2,196 265,601 -27.51

62 30049090 5429312 analgesics & antipyretics, put up in doses/forms/packings for retail (nk)

10,880 34,351 0.01 3,072 7,206 0 0 7,397 79,594 610 29,143 112.46

63 30033100 5422100 medicmnt contg insulin, not put up in doses/forms/packings for retail (nk)

28,000 28,221 0.01 563 52,705 2,444 150,496 206 71,184 814 79,176 -2.53

64 29413000 5413301 terramycin; salts, not put up as medicaments (nk)

6,697 24,844 0.01 49,384 302,100 15,200 20,187 20,415 25,471 2,265 32,772 315.43

65 30019000 5416203 heparin & its salts (nk) 2,512 21,844 0.01 60 95 198 699 1,603 5,761 1,067 7,023 5675.36

66 30041000 5421302 medicmnt w/ streptomycin/dihydrostrep- tomycin in doses/oth for retail (nk)

2,357 17,186 0.00 0 0 0 0 3,055 54,230 38,220 10,449 79.75

67 29396900 5414609 other alkaloids of rye ergot and their derivatives; salts thereof, not put up as medicaments (nk)

17 15,876 0.00 0 0 4 3,745 90 912 86 3,630 33.94

68 29379900 5415909 oth hormones & oth hormone derivtv; oth steroids as hormone,not as medic (nk)

477 15,271 0.00 2,764 27,870 7,155 148,650 19,326 152,765 834 102,991 -20.21

69 30042000 5421903 medicmnt contg terramycin, put up in doses/forms/packings for retail (nk)

1,056 15,157 0.00 0 0 838 20,925 630 3,558 4,471 67,376 73.35

70 29392100 5414201 quinine & its salts, not put up as medicaments (nk)

205 14,131 0.00 105 7,575 100 6,500 197 11,111 477 9,087 20.97

71 30029000 5416403 antitetanic serum [, bulk] (nk) 212 12,573 0.00 838 89,349 129 1,214 731 234,401 3,295 30,664 1934.72



- 41 -

72 30049090 5429305 veterinary medicine for eradication of parasites, for retail sale (nk)

2,679 11,378 0.00 2,000 67,600 0 0 0 0 1,171 10,481 -45.79

73 29379100 5415100 insulin & its salts, not put up as medicaments (nk)

307 10,728 0.00 0 0 4,982 12,783 477 83,158 13 3,016 618.15

74 29419000 5413904 neomycin;salts,not as medicmnt (nk)

899 8,298 0.00 200 2,148 699 5,811 1,187 13,977 3,735 61,914 21.86

75 30031000 5421105 medicmnt w/ penicillin/derivtv,penicillanic acid stru,for veterinary (nk)

6,219 8,076 0.00 255 8,140 0 0 0 0 0 0 -0.20

76 30031000 5421101 medicmnt contg penicillin,not put up in doses/in form/packgs for retail (nk)

341 7,128 0.00 0 0 0 0 0 0 850 25,237 -25.00

77 29396200 5414602 ergotamine (inn) and its salts (nk)

3 5,349 0.00 3 15,908 0 0 0 0 158 23,106 -41.60

78 30033900 5422201 medicmnt w/ antidiabetic preptn, not in doses/forms/packings for retail (nk)

434 3,672 0.00 0 0 0 0 0 0 27 4,526 -25.00

79 30021000 5416303 blood globulins, serum globulins & hemoglobin (nk)

5 2,900 0.00 0 0 1,330 238,065 1,107 195,309 44,130 226,698 -22.99

80 30041000 5421305 medicmnt w/ penicillins/derivtv, etc, for retail sale, for veterinary (nk)

127 2,880 0.00 496 6,535 728 45,252 2,115 11,013 9,187 83,598 20.65

81 30039000 5429107 medicmnt w/ analgesics & antipyretics, not in doses/packg for retail (nk)

400 2,773 0.00 0 0 0 0 0 0 11,459 116,626 -25.00

82 29394900 5414409 other ephedrines and their salts, not put up as medicaments (nk)

18 2,195 0.00 2,000 16,068 0 0 1,068 19,434 527 19,846 -47.11

83 30021000 5416301 antisera [, bulk] (nk) 5 582 0.00 0 0 133 18,448 1,152 64,451 132 20,255 11.71

84 30029000 5416401 human blood (nk) 6 381 0.00 1,734 252,068 532 120,689 41,673 126,508 1,532 76,254 17.58

85 30049090 5429308 glucose, preprd as medicmnt, put up in doses/forms/packings for retail (nk)

157 362 0.00 0 0 0 0 0 0 0 0 0.00

86 29394100 5414401 ephedrine and its salts (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

87 29397000 5414700 nicotine & its salts, not put up as medicaments (nk)

0 0 0.00 0 0 1,000 5,983 0 0 0 0 -25.00

88 29371000 5415200 pituitary(anterior)/simlr hormones, & their derivtv, not as medicment (nk)

0 0 0.00 0 0 150 3,556 82,000 73,445 16,329 82,610 -51.56

89 29379200 5415901 oestrogens & progestogens, not put up as medicaments (nk)

0 0 0.00 185 126,572 20,954 307,252 5,128 160,299 1,415 275,328 -27.23



- 42 -

90 29381000 5416101 rutoside(rutin) & its derivtv, not put up as medicaments (nk)

0 0 0.00 226 49,497 694 124,112 751 119,999 150 31,253 31.82

91 30011000 5416201 glands & oth organs, for organo-therapeutc uses,dried,powdered/not (nk)

0 0 0.00 140 7,182 0 0 0 0 609 16,948 -50.00

92 30022000 5416313 rabies vaccine [, bulk] (nk) 0 0 0.00 0 0 327 204,501 284 47,140 1,252 544,546 35.62

93 30022000 5416321 poliomyelitis and staphylococci vaccines [, bulk] (nk)

0 0 0.00 0 0 0 0 314 21,473 1,389 134,207 -46.00

94 30031000 5421104 medicmnt contg erythromycin,not put up in doses/form/packgs for retail (nk)

0 0 0.00 0 0 0 0 0 0 240 48,275 -25.00

95 30032000 5421202 medicmnt contg chloramphenicol,not in doses/form/packg for retail (nk)

0 0 0.00 95 5,255 158 10,664 0 0 0 0 -37.68

96 30032000 5421203 medicmnt contg terramycin,not put up in doses/forms/packings for retail (nk)

0 0 0.00 300 4,926 0 0 0 0 0 0 -25.00

97 30041000 5421304 medicmnt contg erythromycin,put up in doses/forms/packings for retail (nk)

0 0 0.00 293 43,090 0 0 0 0 1,363 18,499 -50.00

98 30042000 5421901 medicmnt contg bacitracin, put up in doses/forms/packings for retail (nk)

0 0 0.00 2,027 20,905 806 73,206 7,361 172,256 3,280 84,359 -31.19

99 30044000 5423202 medicmnt w/ alkaloids,of cinchona bark, in doses/form/packing for retail (nk)

0 0 0.00 20,080 4,800 0 0 0 0 0 0 -25.00

100 30039000 5429101 medicmnt contg sulfonamides&sulfonamide comp,in dose/packg for retail (nk)

0 0 0.00 0 0 0 0 106,600 117,898 57 7,770 329.34

101 30039000 5429102 medicmnt contg enzymes, not put up in doses/forms/packings for retail (nk)

0 0 0.00 0 0 0 0 0 0 4,384 1,987 -25.00

102 30039000 5429108 medicmnt w/ shcistosomiasis medicine, not in doses/packg for retail (nk)

0 0 0.00 0 0 120 5,622 0 0 0 0 -25.00

103 30049090 5429301 sulfonamides & sulfonamide comp, in doses/forms/packings for retail (nk)

0 0 0.00 762 33,528 0 0 17,967 287,728 35 2,601 2690.55



- 43 -

104 30049090 5429307 anaesthetics, put up in measured doses/ forms/packings for retail sale (nk)

0 0 0.00 760 1,039 0 0 0 0 595 40,450 -50.00

105 30049090 5429311 trypanocidal and antiluetic preptn, in doses/forms/packings for retail (nk)

0 0 0.00 0 0 1,171 5,896 10 1,182 0 0 74.71

Source: Bureau of Export Trade Promotion


- 44 -


- 45 -

ANNEX IV

PHILIPPINE SUPPLYING COUNTRIES OF PHARMACEUTICAL PRODUCTS CIF VALUE IN US DOLLARS (2000 – 2004)

Country 2004 2003 2002 2001 2000 % Share 2004 %Ave. Growth Rate

TOTAL 417,356,623 390,334,843 361,632,590 336,369,863 325,404,975 100.00 6.43

Top 10 305,948,180 274,695,162 255,040,117 238,551,418 230,125,020 73.31 7.41

Others 111,408,443 115,639,681 106,592,473 97,818,445 95,279,955 26.69 4.12

1 Switzerland 50,800,465 44,960,371 36,655,116 32,666,616 37,537,735 12.17 8.72

2 Australia 48,189,754 32,514,878 23,305,190 26,679,636 30,874,415 11.55 15.37

3 France 42,002,998 36,095,598 33,118,211 28,333,168 26,005,034 10.06 12.80

4 Germany 40,251,534 38,555,452 36,655,283 34,623,403 26,340,513 9.64 11.72

5 Great Britain And Northern Ireland 36,623,998 32,814,446 33,725,135 29,323,847 26,536,101 8.78 8.61

6 U.S.A. (Excl. Hawaii & Alaska) 22,398,901 23,365,608 25,053,239 30,522,385 33,046,442 5.37 -9.11

7 Singapore 19,115,214 21,505,074 24,657,195 21,631,243 20,719,465 4.58 -1.38

8 Italy 17,748,974 20,018,290 16,422,214 13,123,014 12,464,364 4.25 10.25

9 Sweden 14,933,643 12,397,106 14,811,885 11,112,321 5,780,613 3.58 32.42

10 Belgium 13,882,699 12,468,339 10,636,649 10,535,785 10,820,338 3.33 6.72

11 India 13,849,341 19,795,306 18,627,069 10,421,101 8,400,888 3.32 19.76

12 Netherlands 13,609,772 15,079,699 10,279,267 10,638,468 10,306,105 3.26 9.20

13 Japan 11,282,165 9,022,673 9,845,556 7,898,338 9,568,553 2.70 5.97

14 Hong Kong S.A.R. 9,881,570 7,593,989 4,882,496 8,089,366 15,745,597 2.37 -0.65

15 China, People'S Rep. Of 9,757,003 10,310,774 7,655,341 7,493,841 4,731,815 2.34 22.46

16 Korea, Rep. Of (South) 6,242,396 5,311,127 5,515,349 7,500,957 4,198,495 1.50 16.50

17 Spain 5,736,324 5,465,941 5,297,215 5,602,299 5,721,569 1.37 0.15

18 Indonesia (Includes West Irian) 5,527,295 4,002,520 3,996,083 5,183,959 4,712,596 1.32 6.34

19 Puerto Rico 5,152,300 4,382,554 3,113,744 1,361,810 823,992 1.23 63.06

20 Denmark 4,826,930 4,545,060 3,369,310 2,482,964 2,594,637 1.16 18.12

21 Thailand 4,427,472 4,243,333 8,759,978 8,233,552 5,797,018 1.06 0.30

22 Ireland 4,171,110 4,698,980 6,888,160 6,463,131 5,551,850 1.00 -5.01

23 Taiwan 3,240,818 3,311,888 2,416,672 2,902,412 2,500,934 0.78 8.55

24 Malaysia 2,905,740 2,673,923 3,069,648 2,149,226 1,960,887 0.70 12.05

25 Austria 2,380,421 6,147,000 6,206,322 5,003,956 4,328,002 0.57 -5.65

26 Pakistan, Islamic Rep. 1,987,156 1,380,234 1,186,623 960,957 1,664,410 0.48 10.38

27 Panama 1,325,704 1,308,524 123,416 398,260 658,937 0.32 213.25

28 Canada 1,058,625 1,012,482 650,468 1,020,481 600,303 0.25 23.49

29 Mexico 710,128 1,380,267 1,953,129 917,133 908,215 0.17 9.02

30 Finland 458,861 910,128 325,586 548,252 670,561 0.11 17.77


- 46 -

31 Brazil 387,828 983,979 632,590 721,448 886,992 0.09 -9.00

32 Turkey 218,089 113,197 0 95,992 1,758 0.05 1338.24

33 Israel 216,210 114,839 58,100 211,324 155,761 0.05 37.27

34 Hungary 189,097 256,070 216,811 237,491 493,802 0.05 -17.17

35 New Zealand (Excludes Western Samoa) 186,260 102,519 46,767 117,865 57,469 0.04 61.42

36 Swaziland 167,169 0 0 0 7,749 0.04 -25.00

37 Argentina 160,856 160,256 256,248 178,793 67,898 0.04 42.39

38 Croatia 156,156 307,690 229,065 216,170 146,423 0.04 9.67

39 Egypt 146,855 0 0 22,032 0 0.04 -25.00

40 Greece 121,844 5,115 0 15,750 646,072 0.03 521.13

41 Poland 113,962 41,685 0 0 11,462 0.03 18.35

42 Macau 111,000 10,000 0 0 60,001 0.03 227.50

43 Papua New Guinea 86,424 0 0 0 0 0.02 0.00

44 South Africa Rep. Of 76,472 189,785 236,015 219,573 271,097 0.02 -22.70

45 Norway 72,512 24,945 0 4,149 92,255 0.02 -1.20

46 Bulgaria 71,600 448,923 123,059 0 11,934 0.02 20.19

47 Cyprus 57,655 46,156 11,170 15,233 17,302 0.01 74.87

48 Portugal 43,965 0 0 16,597 17,009 0.01 -25.61

49 Niger 40,796 0 0 0 0 0.01 0.00

50 Ecuador 39,359 0 0 0 0 0.01 0.00

51 Bangladesh 32,735 21,729 34,078 22,595 45,849 0.01 3.63

52 Czech Republic 32,566 0 90,095 0 2,251 0.01 -50.00

53 Aruba 31,978 0 0 0 0 0.01 0.00

54 Romania 30,654 0 0 80,636 13,501 0.01 99.31

55 Grenada 30,626 0 0 0 0 0.01 0.00

56 Vietnam 28,772 14,079 273 101 11,343 0.01 1308.17

57 Dominica 12,260 4,276 0 0 0 0.00 46.68

58 Trust Territory Of The Pacific Islands 11,391 0 0 434 7,776 0.00 -48.60

59 Macedonia, The Former Yugoslav Rep 1,484 0 0 0 0 0.00 0.00

60 Colombia 465 4,100 0 0 65,183 0.00 -47.16

61 Uruguay 272 30,150 0 60,341 0 0.00 -49.77

62 Afghanistan 0 66,533 0 0 0 0.00 -25.00

63 Alaska 0 1,581 0 0 0 0.00 -25.00

64 Barbados 0 0 0 0 6,893 0.00 -25.00

65 Belize (British Honduras) 0 0 44,023 1,296 58,104 0.00 774.77

66 Burkina Fasso (Upper Volta) 0 0 18,554 0 0 0.00 -25.00

67 Canal Zone 0 8,323 0 0 0 0.00 -25.00

68 Canary Islands 0 0 0 0 161,164 0.00 -25.00

69 Chile 0 0 0 910 298,926 0.00 -49.92

70 Christmas Island 0 0 0 0 33,103 0.00 -25.00

71 Equatorial Guinea, Rep. Of 0 0 0 17,021 0 0.00 -25.00

72 Fiji 0 0 17,572 0 0 0.00 -25.00

73 French Pacific Islands 0 9,808 0 48,685 0 0.00 -50.00


- 47 -

74 French West Indies 0 0 2,495 0 92,538 0.00 -50.00

75 Gambia 0 0 0 0 12,576 0.00 -25.00

76 Honduras 0 67,509 0 0 0 0.00 -25.00

77 Kuwait 0 0 0 0 2,000 0.00 -25.00

78 Luxembourg 0 7,347 245,788 13,168 25,959 0.00 380.07

79 Malta 0 0 12,416 14,500 0 0.00 -28.59

80 Mozambique 0 0 0 1,806 0 0.00 -25.00

81 Myanmar (Burma) 0 0 0 1,182 0 0.00 -25.00

82 Paraguay 0 21,343 0 0 0 0.00 -25.00

83 Peru 0 0 0 0 3,860 0.00 -25.00

84 Saudi Arabia 0 0 0 0 33,901 0.00 -25.00

85 Senegal 0 0 47,979 0 0 0.00 -25.00

86 Slovak Republic (Slovakia) 0 0 0 0 2,688 0.00 -25.00

87 Slovenia 0 0 0 85,619 0 0.00 -25.00

88 Somalia 0 0 284 0 0 0.00 -25.00

89 South And Southeast Asia, N.E.S. 0 0 28,999 0 0 0.00 -25.00

90 Sri Lanka (Ceylon) 0 0 4,018 0 0 0.00 -25.00

91 Suriname 0 0 0 0 7,050 0.00 -25.00

92 Tanzania, United Rep. Of 0 0 0 66,364 0 0.00 -25.00

93 Ukraine (Ukrainian S.S.R) 0 0 74,467 0 0 0.00 -25.00

94 United Arab Emirates 0 0 175 60,907 4,942 0.00 233.18

95 Uzbekistan 0 1,342 0 0 0 0.00 -25.00Source: Bureau of Export Trade Promotion


- 48 -


- 49 -

ANNEX V

PHILIPPINE IMPORTS OF NATURAL PRODUCTS CIF VALUE IN US DOLLARS (2000 – 2004)





-50-

2004 2003 2002 2001 2000

HS PSCC Product Description Quantity Value %Share Quantity Value Quantity Value Quantity Value Quantity Value

%Ave. Growth Rate

TOTAL 43,023,953 100.00 39,452,979 34,266,281 34,600,838 32,245,687 7.63

1 15162010 4312201 hydrogenated vegetable fats in

flakes (nk) 12,603,544 5,898,880 13.71 13,732,449 6,618,030 13,943,690 6,325,136 16,908,730 5,999,830 9,703,068 4,076,352 11.59

2 15162090 4312209 other vegetable fats and oils and their fraction partly or wholly hydrogenated (other than in flakes (nk)

10,214,405 4,762,879 11.07 5,233,722 2,422,712 5,018,751 2,716,256 2,367,667 1,580,597 2,013,728 1,190,483 47.60

3 12122000 2929700 seaweeds and other algae (nk) 5,470,020 4,760,366 11.06 5,507,222 3,721,709 2,167,030 1,756,320 2,796,671 2,088,961 1,397,214 1,378,362 43.86

4 13021200 2929402 liquorice saps & extracts (nk) 361,132 3,741,762 8.70 179,581 1,792,498 859 117,964 2,075 23,438 266,596 2,296,739 458.15

5 13023910 2929603 carrageenan (nk) 435,877 3,682,564 8.56 489,836 4,277,463 600,869 3,099,797 907,943 3,446,758 348,842 2,728,647 10.08

6 13019000 2922909 oth nat gum,gum-resins & balsam (nk)

4,397,749 2,714,851 6.31 4,111,410 3,273,459 4,096,365 3,658,625 3,650,895 3,587,690 2,119,110 2,363,576 6.55

7 15152900 4216900 maize(corn) oil, refined & its fractions (nk)

2,552,835 2,341,567 5.44 991,041 998,470 1,367,675 954,951 1,465,627 1,097,183 1,127,510 1,012,223 33.63

8 13021300 2929403 extracts of hops (nk) 154,120 2,172,809 5.05 110,498 1,658,894 123,648 2,313,616 85,940 1,791,157 107,267 1,600,991 10.93

9 15151900 4221900 linseed oil, refined & its fractions (nk)

1,846,102 1,563,905 3.63 2,220,281 1,808,019 2,319,537 1,432,073 2,644,019 1,563,480 2,017,221 1,269,721 6.87

10 33011900 5513119 oth essential oils of citrus fruits oth for the manufacture of medicine (nk)

110,236 1,516,960 3.53 124,655 2,085,778 129,002 2,365,182 135,876 1,866,060 53,221 750,745 34.06

11 15161000 4312100 animal fats&oils&fractions,hydrogenated inter-/re-esterified/elaidinized (nk)

1,556,681 1,482,605 3.45 1,357,497 1,251,606 1,404,798 933,149 2,246,042 1,390,848 1,958,105 1,597,397 1.69





-51-

12 13023200 2929602 mucilages and thickeners

derived from locust beans, locust bean seeds or guar seed, whether or not m (nk)

518,581 1,281,773 2.98 447,318 1,366,507 301,594 970,945 341,006 1,244,940 372,434 1,807,001 -4.64

13 13022000 2929500 pectic substances, pectinates&pectates (nk)

102,932 911,423 2.12 117,924 961,639 36,178 341,440 25,334 321,270 29,387 173,759 66.90

14 13012000 2922200 gum arabic (nk) 461,729 763,677 1.78 420,314 928,810 448,091 1,007,366 562,997 1,166,476 385,469 872,662 -1.39

15 13023990 2929609 mucilages and thickeners derived from vegetable products, n.e.s., whether or not modified (nk)

126,010 749,201 1.74 118,114 722,463 273,661 1,214,545 254,289 1,073,713 270,428 1,200,499 -8.57

16 13021900 2929409 oth vegetable saps & extracts (nk)

112,175 717,172 1.67 112,956 562,806 67,860 554,431 106,671 656,958 90,580 581,089 6.60

17 15155000 4218000 sesame(sesamum) oil & its fractions (nk)

563,667 614,752 1.43 540,852 606,082 672,172 465,486 614,017 695,029 659,491 583,097 4.45

18 12119000 2924909 other plants and parts of plants (including seeds and fruits) of a kind used primarily in perfumery, (nk)

121,490 478,018 1.11 80,592 291,876 94,952 166,372 106,093 96,811 66,330 146,895 44.24

19 15159000 4229909 other fixed vegetable fats and oils, and their fractions, [crude, refined or fractionated, n.e.s.] w (nk)

512,735 401,972 0.93 395,163 674,856 1,072,083 402,220 2,678,621 1,264,568 2,168,458 1,486,423 -13.95

20 15132900 4224900 palm kernel/babassu oil, refined and fractions thereof (nk)

703,129 384,910 0.89 258,929 53,320 184,685 15,311 1,037,618 368,176 791,388 408,201 191.12

21 33011300 5513111 lemon oil oth for mfr of medcine (nk)

18,437 279,460 0.65 26,735 436,135 10,653 181,738 57,212 574,491 68,512 1,100,189 -3.02

22 15219000 4314109 oth veg waxes, wtr/not colored (nk)

498,554 256,254 0.60 854,035 332,263 1,676,599 448,809 129,728 83,701 45,276 73,329 100.38

23 32030000 5322209 oth coloring matter of veg/animal origin & preptns based thereon (nk)

25,434 212,009 0.49 65,096 215,894 113,887 449,055 223,529 759,530 84,797 462,044 -7.56

24 33011200 5513113 orange oil oth for mfr of medicn (nk)

49,787 177,839 0.41 30,273 392,687 28,875 279,766 27,146 187,352 45,734 241,620 3.13





-52-

25 15153000 4225000 castor oil & its fractions (nk) 80,237 140,770 0.33 158,086 298,469 169,670 149,989 56,834 99,729 125,236 172,494 13.59

26 13019000 2922904 gum, guar (nk) 134,245 132,428 0.31 120,605 149,043 179,721 206,969 116,875 104,765 266,152 394,342 -3.75

27 15211000 4314101 carnauba wax (nk) 23,225 107,052 0.25 21,828 103,345 425,990 161,368 74,640 97,262 35,731 118,603 3.89

28 18040000 0724000 cocoa butter, fat/oil (nk) 277,359 104,528 0.24 51,929 76,023 289,423 259,496 24,697 46,282 16,921 21,329 136.12

29 13023100 2929601 agar-agar, whether or not modified (nk)

15,212 96,861 0.23 5,817 38,278 8,717 45,441 9,272 105,343 32,105 377,727 2.08

30 13011000 2922101 shellac (nk) 19,231 91,127 0.21 29,762 74,342 21,323 55,921 7,638 43,577 5,951 73,166 10.85

31 33011900 5513109 oth essetial oils of citrus fruits for manufacture of medicine (nk)

3,977 78,074 0.18 19,644 322,215 61,417 621,694 102,826 524,956 1,907 95,525 86.01

32 15154000 4229100 tung oil and its fractions, whether or not refined, but not chemically modified (nk)

40,470 74,717 0.17 38,517 49,180 91,270 67,284 92,000 64,972 99,791 90,296 0.13

33 33011200 5513103 orange oil for mfr of medicine (nk)

16,992 72,625 0.17 31,411 112,279 19,786 107,227 6,223 90,182 10,092 96,102 -4.47

34 15219000 4314201 beeswax (nk) 7,300 41,390 0.10 11,397 43,575 9,455 33,313 8,677 45,528 15,975 100,102 -13.89

35 33011400 5513112 lime oil oth for mfr of medicine (nk)

9,086 40,750 0.09 46,100 229,278 410 26,276 2,103 44,479 1,180 67,942 153.73

36 32030000 5322203 food color, of veg/animal origin (nk)

3,101 32,492 0.08 1,429 18,594 1,999 22,024 44 2,019 220 10,514 242.30

37 33011400 5513102 lime oil for mfr of medicine (nk) 302 21,137 0.05 360 17,261 320 11,637 1,089 19,050 1,283 5,532 69.06

38 13019000 2922903 gum, tragacanth (nk) 3,475 19,542 0.05 3,000 41,143 1,000 9,250 61 509 640 7,895 479.01

39 15219000 4314209 oth insect waxes, wtr/not refined/ colored (nk)

13,681 17,552 0.04 29,013 76,251 108,000 99,581 260,309 148,482 41,599 53,156 11.50

40 33011300 5513101 lemon oil for mfr of medicine (nk) 13,868 16,871 0.04 4,894 103,684 3,569 86,444 4,243 83,183 5,771 62,151 -6.51

41 15131900 4223900 coconut(copra) oil, refined & its fractions (gk)

102,297 15,652 0.04 42,303 6,868 930,697 12,789 19,498 8,107 147,999 83,694 12.26

42 13021100 2929401 opium saps & extracts (nk) 10,060 11,314 0.03 0 0 0 0 0 0 0 0 0.00

43 33012300 5513226 lavender/lavandin oil (nk) 760 10,922 0.03 275 3,778 292 4,595 638 11,358 191 2,668 109.37

44 13019000 2922905 resin, natural (nk) 790 8,451 0.02 0 0 31,400 20,530 51,557 12,482 54,895 82,537 -30.10

45 32030000 5322201 natural indigo (nk) 44,440 7,137 0.02 2,000 22,962 0 0 0 0 0 0 -17.23





-53-

46 33011100 5513121 bergamot oil (nk) 179 5,861 0.01 245 10,519 949 7,922 2,243 11,521 0 0 -10.69

47 12112000 2924200 ginseng roots (nk) 1,946 4,625 0.01 5,733 9,728 0 0 91 2,169 906 2,783 -43.63

48 15089000 4213900 groundnut(peanut) oil, refined & its fractions (nk)

3,830 2,489 0.01 2,942 2,347 8,437 7,388 5,209 8,649 16,118 13,594 -28.29

49 32030000 5322202 annatto(achuete) (nk) 600 1,246 0.00 20,185 38,382 17,515 23,518 80 3,920 6,789 35,165 94.39

50 13021400 2929404 extracts of pyrethrum/roots of plants contg rotenone (nk)

63 271 0.00 0 0 0 0 0 0 26,006 19,460 -25.00

51 15081000 4213100 groundnut(peanut) oil, crude (nk) 207 216 0.00 0 0 0 0 3,400 9,400 955 473 446.83

52 13019000 2922902 gum, elemi (nk) 68 160 0.00 0 0 1,200 1,296 0 0 27,360 96,307 -50.00

53 15219000 4314202 spermaceti, crude, pressed/refined, wtr/not colored (nk)

120 85 0.00 0 0 0 0 0 0 0 0 0.00

54 13011000 2922109 oth lac (nk) 0 0 0.00 4,429 74,765 664 15,653 3,332 29,847 940 8,448 120.85

55 13019000 2922901 resin, copal(almaciga) (nk) 0 0 0.00 18,000 8,867 544 806 1,196 7,085 0 0 202.88

56 13019000 2922906 incense & myrrh (nk) 0 0 0.00 0 0 500 8,680 52,500 17,325 4,011 1,180 304.58

57 12111000 2924100 liquorice roots (nk) 0 0 0.00 1,000 1,500 0 0 0 0 1,309 3,081 -50.00

58 12119000 2924901 eucalyptus leaves (nk) 0 0 0.00 5,847 8,696 0 0 72 925 800 481 -26.92

59 12119000 2924902 cinchona bark (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

60 12119000 2924903 cedar powder (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

61 12119000 2924904 pyrethrum (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

62 15152100 4216100 maize(corn) oil, crude (nk) 0 0 0.00 21,942 14,530 0 0 10,003 5,866 787 822 103.41

63 15151100 4221100 linseed oil, crude (nk) 0 0 0.00 22,800 21,504 0 0 767 533 65,260 38,540 -74.66

64 15131100 4223100 coconut(copra)oil, crude (gk) 0 0 0.00 0 0 0 0 0 0 264,355 110,502 -25.00

65 15132100 4224100 palm kernel/babassu oil, crude (nk)

0 0 0.00 0 0 24,065 9,095 0 0 933,699 596,661 -50.00





-54-

66 15159000 4229901 tobacco seed oil and its

fractions, whether or not refined, but not chemically modified (nk)

0 0 0.00 14,232 7,658 98,641 19,157 393,468 22,316 0 0 -43.55

67 15159000 4229902 jojoba oil and its fractions, whether or not refined, but not chemically modified (nk)

0 0 0.00 16 491 16 385 0 0 116 371 -43.12

68 15159000 4229903 oiticica oil and its fractions, [refined, solidified or hardened by mechanical means] whether or not (nk)

0 0 0.00 2,010 13,448 0 0 0 0 0 0 -25.00



- 55 -

ANNEX VI

PHILIPPINE SUPPLYING COUNTRIES OF NATURAL PRODUCTS CIF VALUE IN US DOLLARS (2000 – 2004)

Country 2004 2003 2002 2001 2000

% Share 2004

% Ave. Growth

Rate

TOTAL 43,023,953 39,452,979 34,266,281 34,600,838 32,245,687 100.00 7.63 Top 10 35,998,207 32,776,005 27,220,309 26,736,235 23,723,284 83.67 11.19 Others 7,025,746 6,676,974 7,045,972 7,864,603 8,522,403 16.33 -4.54

1 Malaysia 9,316,343 6,911,169 5,387,966 5,277,706 4,002,421 21.65 24.262 U.S.A. (Excl. Hawaii & Alaska) 8,791,123 8,295,870 6,919,045 6,961,258 8,303,810 20.43 2.27

3 Indonesia (Includes West Irian) 4,693,073 3,941,203 2,245,434 3,136,944 1,195,477 10.91 57.14

4 Singapore 3,664,090 3,483,449 5,365,512 4,290,504 3,751,145 8.52 2.395 Denmark 3,073,282 3,682,772 2,415,554 2,624,377 2,171,870 7.14 12.206 China, People'S Rep. Of 1,530,063 735,423 595,459 427,246 381,911 3.56 45.707 Belgium 1,508,040 1,471,010 339,256 73,479 30,836 3.51 209.038 India 1,231,491 1,077,767 941,900 1,052,635 1,141,484 2.86 2.609 Germany 1,180,175 1,943,100 2,205,335 1,532,128 1,563,466 2.74 -2.30

10 France 1,010,527 1,234,242 804,848 1,359,958 1,180,864 2.35 2.3911 Chile 922,328 417,010 631,536 961,300 1,387,339 2.14 5.55

12 Great Britain And Northern Ireland 897,226 591,088 1,140,108 1,324,100 1,618,489 2.09 -7.11

13 Norway 729,765 630,928 402,626 459,516 227,894 1.70 40.4114 Hong Kong S.A.R. 723,877 1,124,143 1,134,359 852,177 852,127 1.68 -0.8515 Netherlands 518,014 319,818 136,086 154,680 266,680 1.20 35.7416 Australia 492,044 584,280 767,969 941,308 924,946 1.14 -14.0917 Thailand 487,606 430,596 647,677 556,376 522,220 1.13 0.6718 Spain 381,672 84,303 232,288 406,090 203,930 0.89 86.3419 Japan 246,696 578,039 334,226 353,019 438,620 0.57 -2.3020 Canada 242,591 126,021 275,462 87,563 277,500 0.56 46.1021 Taiwan 191,449 142,084 435,616 569,237 390,552 0.44 -2.5922 Brazil 153,757 148,139 71,447 30,266 150,584 0.36 41.8223 Vietnam 149,950 142,574 112,737 0 0 0.35 7.9124 Mexico 128,917 139,710 161,823 129,583 101,683 0.30 7.7325 Italy 126,057 253,944 147,339 184,794 198,720 0.29 -1.3226 Korea, Rep. Of (South) 92,011 34,251 32,055 277,699 452,631 0.21 12.1027 Pakistan, Islamic Rep. 89,789 106,359 122,937 116,811 94,839 0.21 -0.1628 Morocco 77,494 155,614 0 222,220 76,470 0.18 10.1029 South Africa Rep. Of 75,333 121,955 97,629 0 0 0.18 -3.3330 Peru 72,263 64,055 0 0 0 0.17 3.2031 Argentina 56,142 114,075 2,114 15,788 0 0.13 1289.6932 Ireland 52,137 0 0 0 6,334 0.12 -25.0033 Turkey 43,612 327 221 415 496 0.10 3305.47


- 56 -

34 New Zealand (Excludes Western Samoa) 15,213 6,607 14,733 13,190 0 0.04 21.70

35 Hawaii 13,998 0 0 0 0 0.03 0.0036 Israel 13,600 20,398 10,199 9,822 8,598 0.03 21.1937 Switzerland 13,253 79,908 63,513 107,274 214,468 0.03 -37.0938 Austria 6,824 62,400 0 61,920 62,785 0.02 -47.6139 Uzbekistan 5,602 0 0 0 0 0.01 0.0040 Aruba 3,114 0 0 0 0 0.01 0.0041 Nepal 1,464 51,521 0 0 0 0.00 -24.2942 Papua New Guinea 1,115 0 0 0 0 0.00 0.0043 Sweden 382 771 4,101 4,965 5,407 0.00 -39.3144 Czech Republic 257 0 0 0 0 0.00 0.0045 Guam 194 0 0 0 0 0.00 0.0046 Benin 0 12,400 0 0 0 0.00 -25.0047 Ceuta And Melilla 0 0 37,620 0 0 0.00 -25.0048 Christmas Island 0 0 1,543 0 0 0.00 -25.0049 Guatemala 0 3,148 0 0 0 0.00 -25.0050 Hungary 0 75,566 0 348 0 0.00 -50.0051 Iceland 0 0 0 0 2,035 0.00 -25.0052 Kenya 0 0 0 0 15,000 0.00 -25.0053 Malta 0 50,425 0 1,806 0 0.00 -50.0054 Mozambique 0 0 23,378 0 0 0.00 -25.0055 Myanmar (Burma) 0 0 0 650 8,700 0.00 -48.1356 Portugal 0 0 0 18,225 12,225 0.00 -12.7357 Saudi Arabia 0 0 0 3,036 0 0.00 -25.0058 St. Helena 0 4,366 0 0 0 0.00 -25.0059 Sudan 0 0 4,630 425 0 0.00 222.35

60 Trust Territory Of The Pacific Islands 0 151 0 0 0 0.00 -25.00

61 United Arab Emirates 0 0 0 0 1,131 0.00 -25.00Source: Bureau of Export Trade Promotion


- 57 -

ANNEX VII

PHILIPPINE EXPORTS OF PHARMACEUTICAL PRODUCTS FOB VALUE IN US DOLLARS (2000 – 2004)





- 58 -

2004 2003 2002 2001 2000

HS PSCC Product Description Quantity Value %Share Quantity Value Quantity Value Quantity Value Quantity Value %Ave. Growth Rate

TOTAL 20,778,760 100.00 17,467,826 16,739,713 16,483,186 16,231,188

6.60

1 30049090 5429319 oth medicmnt w/ oth medicinal & pharmaceutical prodct, nes, for retail sale (nk)

15,455,656 14,971,004 72.05 12,754,207 12,304,177 9,763,554 10,909,655 7,100,349 10,295,723 5,891,345 9,221,126 13.02

2 30045000 5429200 medicmnt w/ vit/oth prodct of 5411, in doses/forms/packings for retail (nk)

481,899 2,316,006 11.15 415,093 2,513,667 420,596 3,194,454 457,146 2,860,914 676,575 3,684,877 -9.97

3 30049090 5429312 analgesics & antipyretics, put up in doses/forms/packings for retail (nk)

201,858 1,343,960 6.47 103,088 777,859 134,491 1,015,466 110,521 832,218 163,528 1,304,987 8.79

4 30049090 5429303 medicated candies,cough-syrups&drops,in doses/forms/packings for retail (nk)

181,227 970,373 4.67 174,388 725,724 173,742 687,259 373,510 1,399,268 238,139 990,472 7.43

5 29413000 5413909 oth antibiotics, & salts, nes, not put up as medicaments (nk)

6,350 426,450 2.05 0 0 0 0 236 3,195 239 6,750 -38.17

6 30042000 5421909 medicmnt w/ oth antibiotics,nes, in doses/forms/packg for retail (nk)

49,052 366,160 1.76 48,761 533,523 27,107 312,259 44,724 693,812 48,188 611,054 -0.49

7 30039000 5429119 oth medicmnt, nes, not put up in doses/forms/packings for retail (nk)

124,081 174,014 0.84 143,925 92,671 256,922 131,465 8,025 9,585 285 1,475 469.92

8 30022000 5416329 other vaccines for human medicine [, bulk] (nk)

172 114,624 0.55 44 11,177 0 0 0 0 264 23,953 206.38

9 30049090 5429306 veterinary medicmnt doses/forms/packg/ for retail sale, oth thn 5429305 (nk)

3,305 55,731 0.27 68,377 118,602 52,991 280,307 5,999 145,652 2,467 37,634 67.19

10 30042000 5421903 medicmnt contg terramycin, put up in doses/forms/packings for retail (nk)

384 9,383 0.05 0 0 454 9,396 6 110 1,417 25,599 2060.56

11 30023000 5416341 veterinary vaccines against foot and mouth disease [, bulk] (nk)

263 8,585 0.04 58 4,617 472 6,609 0 0 0 0 13.95

12 30031000 5421105 medicmnt w/ penicillin/derivtv,penicillanic acid stru,for veterinary (nk)

551 7,650 0.04 262 710 0 0 0 0 1,442 7,025 219.37

13 30029000 5416405 toxins, cultures of micro-organisms (excluding yeasts) and similar products [, bulk] (nk)

955 6,482 0.03 720 4,576 76 605 0 0 76 561 149.50





- 59 -

14 29362900 5411600 oth vits & their derivtv;unmixed

(nk) 618 3,956 0.02 75 969 492 8,568 3,388 123,880 167 5,213 600.72

15 30041000 5421305 medicmnt w/ penicillins/derivtv, etc, for retail sale, for veterinary (nk)

87 2,449 0.01 287 25,448 1,000 900 0 0 177 4,115 634.30

16 29372900 5415309 oth adrenal cortical homrones & their derivtv, not as medicaments (nk)

33 1,680 0.01 0 0 0 0 0 0 0 0 0.00

17 29362800 5411500 vit e & its derivatives,unmixed (nk) 32 100 0.00 0 0 0 0 870 25,027 1,244 30,531 -29.51

18 30039000 5429107 medicmnt w/ analgesics & antipyretics, not in doses/packg for retail (nk)

98 100 0.00 0 0 0 0 0 0 0 0 0.00

19 30021000 5416309 other blood fractions and modified immunological products, whether or not obtained by means of biote (nk)

18 53 0.00 0 0 0 0 0 0 252 4,195 -25.00

20 29361000 5411100 provitamins, unmixed (nk) 0 0 0.00 3,500 4,332 5,693 20,584 0 0 0 0 -44.74

21 29362100 5411200 vit a & their derivatives,unmixd (nk)

0 0 0.00 0 0 0 0 0 0 261 400 -25.00

22 29362600 5411305 vit b12 & its derivatives,unmixd (nk)

0 0 0.00 0 0 0 0 61 5,069 0 0 -25.00

23 29362700 5411400 vit c & its derivatives,unmixed (nk) 0 0 0.00 14,579 111,214 50 3,450 266 11,239 475 3,563 792.43

24 29369000 5411700 intermixtures of provitamins & vitamins wtr/not in any solvent (nk)

0 0 0.00 0 0 9,867 24,552 350 3,766 36,750 164,688 88.56

25 29393000 5414300 caffeine & its salts,not put up as medicaments (nk)

0 0 0.00 500 5,295 2,500 25,947 481 4,940 4,500 25,719 41.22

26 30019000 5416209 oth human/animal subs preprd for therapeutic/prophylactic uses (nk)

0 0 0.00 1 300 0 0 0 0 0 0 -25.00

27 30021000 5416301 antisera [, bulk] (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

28 30021000 5416303 blood globulins, serum globulins & hemoglobin (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

29 30022000 5416311 cholera, dysentery and typhoid vaccine [, bulk] (nk)

0 0 0.00 0 0 0 0 9 32,645 0 0 -25.00

30 30022000 5416313 rabies vaccine [, bulk] (nk) 0 0 0.00 119 60,000 0 0 0 0 0 0 -25.00

31 30022000 5416321 poliomyelitis and staphylococci vaccines [, bulk] (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

32 30023000 5416349 other veterinary vaccines [,bulk] (nk)

0 0 0.00 152 14,364 34 5,239 0 0 24 2,600 -6.46

33 30029000 5416401 human blood (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

34 30029000 5416402 animal blood preprd for therapeutic, prophylactic/diagnostic uses (nk)

0 0 0.00 192 709 0 0 0 0 0 0 -25.00





- 60 -

35 30032000 5421203 medicmnt contg terramycin,not put up in doses/forms/packings for retail (nk)

0 0 0.00 0 0 0 0 109 1,924 0 0 -25.00

36 30032000 5421204 medicmnt contg oth antibiotics for vete rinary,not doses/form for retail (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

37 30032000 5421209 medicmnt contg oth antibiotics (nk)

0 0 0.00 0 0 1,604 10,953 0 0 0 0 -25.00

38 30041000 5421301 medicmnt contg penicillin, put up in doses/forms/packings for retail (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

39 30041000 5421302 medicmnt w/ streptomycin/dihydrostrep- tomycin in doses/oth for retail (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

40 30041000 5421304 medicmnt contg erythromycin,put up in doses/forms/packings for retail (nk)

0 0 0.00 0 0 2,838 30,759 786 11,199 988 10,948 19.24

41 30041000 5421309 oth medicmnt w/ penicillins/derivtv,etc in doses/form/packing for retail (nk)

0 0 0.00 1,040 31,579 139 620 0 0 0 0 1223.35

42 30042000 5421904 medicmnt w/ oth antibiotics for veterinary use,in doses/oth for retail (nk)

0 0 0.00 0 0 623 50,256 138 4,155 70 975 333.92

43 30043200 5422400 medicmnt contg adrenal cortex hormones, in doses/forms/packg for retail (nk)

0 0 0.00 685 11,400 0 0 0 0 0 0 -25.00

44 30043900 5422900 medicmnt w/ oth-hormone/prodct of 5415, in doses/forms/packgs for retail (nk)

0 0 0.00 537 4,398 118 1,045 1 790 207 5,121 42.14

45 30049090 5429301 sulfonamides & sulfonamide comp, in doses/forms/packings for retail (nk)

0 0 0.00 0 0 39 216 0 0 0 0 -25.00

46 30049090 5429305 veterinary medicine for eradication of parasites, for retail sale (nk)

0 0 0.00 6,986 94,400 218 6,320 572 6,444 1,300 14,041 309.41

47 30049010 5429314 specialized medicines for cancer, aids and other dreaded diseases (nk)

0 0 0.00 9,500 16,115 71 2,829 104 11,631 539 14,884 68.03

48 30049090 5429315 water, medicinal, distilled, packed for retail (nk)

0 0 0.00 0 0 0 0 0 0 5,770 28,682 -25.00



- 61 -

ANNEX VIII

PHILIPPINE EXPORTS MARKETS OF PHARMACEUTICAL PRODUCTS FOB VALUE IN US DOLLARS (2000 – 2004)

2004 2003 2002 2001 2000 % Share

2004 % Ave. Growth

Rate TOTAL 20,778,760 17,467,826 16,739,713 16,483,186 16,231,188 100.00 6.60 Top 10 16,506,167 13,374,190 14,060,839 13,965,383 13,316,096 79.44 6.02 Others 4,272,593 4,093,636 2,678,874 2,517,803 2,915,092 20.56 12.49

1 Vietnam 2,904,065 2,577,554 2,243,450 2,052,117 1,903,982 13.98 11.172 Australia 2,732,157 2,146,801 2,872,482 3,991,715 2,827,455 13.15 3.793 Myanmar (Burma) 2,485,438 1,460,504 1,491,846 1,429,642 1,692,097 11.96 14.234 Thailand 1,706,474 1,474,793 1,349,810 1,112,361 702,561 8.21 26.165 Malaysia 1,500,728 1,774,829 2,299,603 1,811,272 1,886,775 7.22 -3.836 Singapore 1,301,989 1,270,672 1,504,865 1,341,441 1,361,786 6.27 -0.607 Hong Kong S.A.R. 1,068,694 1,305,741 1,306,177 1,492,252 2,072,369 5.14 -14.668 South Africa Rep. Of 1,032,675 239,796 0 0 0 4.97 82.669 Indonesia (Includes West

Irian) 1,014,500 391,480 353,434 128,769 136,361 4.88 84.70

10 Sri Lanka (Ceylon) 759,447 732,020 639,172 605,814 732,710 3.65 1.6211 Taiwan 547,991 433,531 874,865 572,015 732,276 2.64 1.7512 India 502,008 251,697 176,466 10,674 120,352 2.42 401.0513 Great Britain And Northern

Ireland 462,828 1,828 8,486 178,451 6,138 2.23 6,963.11

14 Sudan 426,050 359,991 0 157,978 33,683 2.05 71.8415 Cambodia (Democratic

Kampuchea) 363,321 903,425 439,030 322,371 314,443 1.75 21.18

16 Korea, Rep. Of (South) 337,232 195,014 163,270 37,315 2,000 1.62 548.9217 U.S.A. (Excl. Hawaii &

Alaska) 241,602 83,959 157,585 184,530 347,636 1.16 19.88

18 Dominican Republic 187,365 96,987 0 0 0 0.90 23.3019 Micronesia Federated

States Of 165,909 14,525 388 2,979 7,480 0.80 1,134.66

20 United Arab Emirates 128,474 390,112 102,285 138,384 191,891 0.62 40.0921 China, People'S Rep. Of 127,014 14,895 6,823 10,647 24,014 0.61 194.8622 Japan 101,725 378,921 109,747 73,393 102,797 0.49 48.2623 New Zealand (Excludes

Western Samoa) 93,622 45,394 97,336 17,967 58,160 0.45 106.38

24 Italy 72,450 28,500 419 57,635 0 0.35 1,689.2125 Netherlands 67,559 58,366 191,445 63,824 33,634 0.33 58.9926 Pakistan, Islamic Rep. 64,642 131,844 36,036 3,761 23,775 0.31 247.2227 Nepal 57,083 0 0 0 0 0.27 0.0028 Germany 33,867 178,568 0 2,100 25,882 0.16 -68.2329 Uganda 33,766 70,682 14,157 0 19,556 0.16 61.7630 Spain 24,543 13,767 20,929 129,687 60,038 0.12 19.0531 Jamaica 23,618 22,201 4,217 10,648 14,898 0.11 85.9832 Laos 21,995 33,379 22,277 20,334 14,474 0.11 16.4433 Sweden 19,640 0 10,080 0 143,668 0.09 -50.0034 Israel 17,864 0 0 0 0 0.09 0.0035 Central African Republic 16,196 0 0 0 0 0.08 0.0036 Kenya 16,167 28,461 30,854 13,306 49,022 0.08 2.02


- 62 -

37 Bahrain 15,550 35,039 20,444 9,363 35,270 0.07 15.1738 Trinidad And Tobago 13,268 31,740 14,522 27,157 51,294 0.06 -8.3039 Greece 11,481 0 0 0 0 0.06 0.0040 Saudi Arabia 10,746 11,641 45,135 0 360,504 0.05 -45.4741 Finland 10,169 0 0 0 0 0.05 0.0042 Switzerland 9,630 57,433 0 5,462 4,620 0.05 -41.2543 Guam 9,035 47,763 7,403 3,140 5,042 0.04 140.5444 Trust Territory Of The

Pacific Islands 6,809 26,658 23,515 13,556 8,340 0.03 18.73

45 Norway 5,040 1,536 0 0 2,019 0.02 32.0346 Portugal 4,800 0 0 0 0 0.02 0.0047 Ethiopia 4,760 8,678 0 0 0 0.02 -11.2948 Russian Federation

(U.S.S.R.) 2,834 0 0 0 0 0.01 0.00

49 Hawaii 2,684 5,859 1,643 3,090 1,643 0.01 60.9150 Canada 1,959 5,141 3,637 3,599 10,104 0.01 -20.9751 Palau, Rep. Of 1,917 1,112 1,739 1,106 17,258 0.01 -0.0152 Qatar 1,649 2,123 1,030 2,205 0 0.01 7.6353 Oman 1,599 1,621 7,200 2,397 0 0.01 30.3854 Papua New Guinea 911 16,530 0 2,738 3,854 0.00 -55.8655 Tanzania, United Rep. Of 810 0 0 0 0 0.00 0.0056 Cook Island 622 0 0 0 0 0.00 0.0057 France 575 168 0 17,970 456 0.00 995.7658 Brunei Darussalam 542 105 2,117 4,207 17,547 0.00 48.8659 Marshall Islands Rep. Of 355 20,417 0 64 209 0.00 -66.9160 Lebanon 184 166 191 3,013 0 0.00 -23.9861 Honduras 133 0 0 23,778 0 0.00 -25.0062 Algeria 0 0 8,829 0 0 0.00 -25.0063 American Samoa 0 0 0 207 291 0.00 -32.2264 Aruba 0 0 0 0 192 0.00 -25.0065 Austria 0 29,760 0 0 29 0.00 -50.0066 Bahamas 0 0 0 0 11,858 0.00 -25.0067 Bangladesh 0 0 0 66,084 1,500 0.00 1,051.4068 Barbados 0 0 349 0 0 0.00 -25.0069 Belgium 0 6,990 0 137,001 4,876 0.00 627.4370 Brazil 0 4,332 0 0 0 0.00 -25.0071 Chile 0 12,059 0 26,634 0 0.00 -50.0072 Christmas Island 0 0 0 3,600 0 0.00 -25.0073 Colombia 0 9,207 0 1,187 0 0.00 -50.0074 Cuba 0 0 0 70,786 0 0.00 -25.0075 Cyprus 0 30 259 457 1,744 0.00 -76.3876 Egypt 0 9,819 0 7,527 0 0.00 -50.0077 French West Indies 0 0 10,222 0 0 0.00 -25.0078 Gibraltar 0 5,818 0 0 0 0.00 -25.0079 Ireland 0 42 254 5,401 0 0.00 -69.6980 Kuwait 0 50 0 0 0 0.00 -25.0081 Macau 0 0 0 496 0 0.00 -25.0082 Malawi 0 0 18,674 3,309 0 0.00 91.0883 Mexico 0 5,222 0 132 37,166 0.00 -74.9184 Mozambique 0 0 13,000 0 0 0.00 -25.0085 Netherlands Antilles 0 0 0 3,087 0 0.00 -25.0086 Nigeria 0 0 0 42,004 13,459 0.00 28.0287 Puerto Rico 0 0 204 2,653 0 0.00 -48.08


- 63 -

88 Swaziland 0 0 0 375 0 0.00 -25.0089 Vanuatu (New Hebrides) 0 530 412 0 0 0.00 -17.8490 Virgin Islands (British) 0 0 23,012 0 0 0.00 -25.0091 Zambia 0 0 8,388 16,019 0 0.00 -36.91



- 64 -


- 65 -

ANNEX IX

PHILIPPINE EXPORTS OF NATURAL PRODUCTS FOB VALUE IN US DOLLARS (2000 – 2004)





-66-

2004 2003 2002 2001 2000

HS PSCC Quantity Value %Share Quantity Value Quantity Value Quantity Value Quantity Value %Ave. Growth Rate

TOTAL 673,087,220 100.00 1,231,645,065 596,987,621 987,413,104 433,440,276 1,462,546,562 496,989,570 1,120,482,389 557,488,757 6.71

1 15131100 4223100 coconut(copra)oil, crude (gk)

703,251,829 416,727,139 61.91 962,573,997 399,435,958 766,811,048 279,672,033 1,191,860,716 340,853,510 832,952,113 350,912,292 6.58

2 15131900 4223900 coconut(copra) oil, refined & its fractions (gk) 255,898,785 161,062,421 23.93 223,781,454 105,424,316 177,850,087 72,953,171 226,113,791 76,695,525 227,997,970 113,183,312 15.04

3 13023910 2929603 carrageenan (nk)

11,949,144 53,764,919 7.99 10,076,729 47,164,916 8,017,652 38,383,091 8,542,425 38,239,377 7,642,265 38,353,940 9.24

4 12122000 2929700 seaweeds and other algae (nk)

32,191,438 35,872,002 5.33 31,100,197 33,134,333 31,063,629 33,859,858 31,738,261 32,950,471 48,021,520 46,409,802 -5.03

5 18040000 0724000 cocoa butter, fat/oil (nk)

1,593,331 4,125,122 0.61 3,072,392 10,285,163 2,838,874 6,899,586 3,318,716 6,456,152 2,678,363 6,358,861 -0.61

6 12119000 2924909

other plants and parts of plants (including seeds and fruits) of a kind used primarily in perfumery, (nk) 139,519 349,404 0.05 83,509 351,561 116,168 203,312 118,080 183,184 70,525 75,138 56.78

7 32030000 5322202 annatto(achuete) (nk)

68,538 341,454 0.05 67,197 309,614 78,589 462,769 41,907 332,539 28,660 347,778 2.99

8 13019000 2922901 resin, copal(almaciga) (nk)

230,403 221,658 0.03 199,159 174,809 209,080 149,893 203,500 160,659 319,368 241,508 0.81

9 13019000 2922902 gum, elemi (nk)

143,581 192,776 0.03 180,500 264,168 135,850 240,830 296,168 528,342 376,842 695,597 -23.95

10 13012000 2922200 gum arabic (nk)

37,700 132,069 0.02 0 0 0 0 100 393 0 0 -25.00

11 15153000 4225000 castor oil & its fractions (nk)

142,956 131,900 0.02 334,210 288,365 142,400 105,480 94,840 60,460 351,405 250,534 29.43

12 13021900 2929409 oth vegetable saps & extracts (nk) 16,091 83,035 0.01 20,383 77,620 80,250 238,292 23,886 342,485 7,245 25,822 283.87

13 13019000 2922909 oth nat gum,gum-resins & balsam (nk) 41,065 36,422 0.01 29,308 53,685 34,689 94,239 134,742 137,894 23,101 39,199 36.23

14 33011300 5513111 lemon oil oth for mfr of medcine (nk) 4,680 30,083 0.00 0 0 22,529 122,303 182 910 618 11,106 3287.02

15 13023990 2929609

mucilages and thickeners derived from vegetable products, n.e.s., whether or not modified (nk) 1,000 5,585 0.00 0 0 7,575 44,518 0 0 0 0 -25.00

16 15219000 4314109 oth veg waxes, wtr/not colored (nk) 14,400 4,785 0.00 0 0 0 0 0 0 543 2,716 -25.00

17 33011900 5513119

oth essential oils of citrus fruits oth for the manufacture of medicine (nk) 390 2,072 0.00 10 298 135 727 3,154 5,227 1 47 2867.87

18 15155000 4218000 sesame(sesamum) oil & its fractions (nk) 456 1,140 0.00 450 1,362 0 0 0 0 0 0 -4.08





-67-

19 32030000 5322209

oth coloring matter of veg/animal origin & preptns based thereon (nk) 83 1,022 0.00 100,000 4,015 0 0 0 0 106 273 -43.64

20 15219000 4314201 beeswax (nk)

270 810 0.00 0 0 35 117 0 0 0 0 -25.00

21 32030000 5322203 food color, of veg/animal origin (nk) 180 609 0.00 0 0 0 0 0 0 0 0 0.00

22 33012200 5513225 jasmin oil (nk)

108 419 0.00 0 0 0 0 0 0 0 0 0.00

23 33012300 5513226 lavender/lavandin oil (nk)

96 374 0.00 15 49 0 0 177 2,193 0 0 140.82

24 13011000 2922101 shellac (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

25 13011000 2922109 oth lac (nk)

0 0 0.00 0 0 0 0 0 0 285 360 -25.00

26 13019000 2922903 gum, tragacanth (nk)

0 0 0.00 0 0 250 5,015 0 0 0 0 -25.00

27 13019000 2922904 gum, guar (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

28 13019000 2922905 resin, natural (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

29 13019000 2922906 incense & myrrh (nk)

0 0 0.00 0 0 200 500 0 0 0 0 -25.00

30 12111000 2924100 liquorice roots (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

31 12112000 2924200 ginseng roots (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

32 12119000 2924901 eucalyptus leaves (nk)

0 0 0.00 51 153 0 0 0 0 0 0 -25.00

33 12119000 2924902 cinchona bark (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

34 12119000 2924903 cedar powder (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

35 12119000 2924904 pyrethrum (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

36 13021100 2929401 opium saps & extracts (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

37 13021200 2929402 liquorice saps & extracts (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

38 13021300 2929403 extracts of hops (nk)

0 0 0.00 4 34 0 0 0 0 0 0 -25.00

39 13021400 2929404 extracts of pyrethrum/roots of plants contg rotenone (nk) 0 0 0.00 0 0 0 0 0 0 9,016 541,120 -25.00

40 13022000 2929500 pectic substances, pectinates&pectates (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

41 13023100 2929601 agar-agar, whether or not modified (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

42 13023200 2929602

mucilages and thickeners derived from locust beans, locust bean seeds or guar seed, whether or not m (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

43 15081000 4213100 groundnut(peanut) oil, crude (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00





-68-

44 15089000 4213900 groundnut(peanut) oil, refined & its fractions (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

45 15152100 4216100 maize(corn) oil, crude (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

46 15152900 4216900 maize(corn) oil, refined & its fractions (nk) 0 0 0.00 0 0 0 0 55,860 38,264 0 0 -25.00

47 15151100 4221100 linseed oil, crude (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

48 15151900 4221900 linseed oil, refined & its fractions (nk) 0 0 0.00 0 0 3,900 3,315 0 0 0 0 -25.00

49 15132100 4224100 palm kernel/babassu oil, crude (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

50 15132900 4224900 palm kernel/babassu oil, refined and fractions thereof (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

51 15154000 4229100

tung oil and its fractions, whether or not refined, but not chemically modified (nk) 0 0 0.00 9,500 12,762 0 0 0 0 0 0 -25.00

52 15159000 4229901

tobacco seed oil and its fractions, whether or not refined, but not chemically modified (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

53 15159000 4229902

jojoba oil and its fractions, whether or not refined, but not chemically modified (nk) 0 0 0.00 0 0 0 0 0 0 8 301 -25.00

54 15159000 4229903

oiticica oil and its fractions, [refined, solidified or hardened by mechanical means] whether or not (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

55 15159000 4229909

other fixed vegetable fats and oils, and their fractions, [crude, refined or fractionated, n.e.s.] w (nk) 0 0 0.00 16,000 4,440 0 0 0 0 0 0 -25.00

56 15161000 4312100

animal fats&oils&fractions,hydrogenated inter-/re-esterified/elaidinized (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

57 15162010 4312201 hydrogenated vegetable fats in flakes (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

58 15162090 4312209

other vegetable fats and oils and their fraction partly or wholly hydrogenated (other than in flakes (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

59 15211000 4314101 carnauba wax (nk)

0 0 0.00 0 0 164 1,227 2 50 279 2,327 539.04

60 15219000 4314202

spermaceti, crude, pressed/refined, wtr/not colored (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00





-69-

61 15219000 4314209 oth insect waxes, wtr/not refined/ colored (nk) 0 0 0.00 0 0 0 0 0 0 0 0 0.00

62 32030000 5322201 natural indigo (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

63 33011300 5513101 lemon oil for mfr of medicine (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

64 33011400 5513102 lime oil for mfr of medicine (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

65 33011200 5513103 orange oil for mfr of medicine (nk) 0 0 0.00 0 0 0 0 30 1,242 60 2,392 -37.02

66 33011900 5513109

oth essetial oils of citrus fruits for manufacture of medicine (nk)

0 0 0.00 0 0 0 0 0 0 0 0 0.00

67 33011400 5513112 lime oil oth for mfr of medicine (nk) 0 0 0.00 0 0 0 0 25 693 2,096 34,332 -49.50



- 70 -


- 71 -

ANNEX X

PHILIPPINE EXPORT MARKETS OF NATURAL PRODUCTS FOB VALUE IN US DOLLARS (2000 – 2004)

Country 2004 2003 2002 2001 2000

% Share 2004

% Ave. Growth

Rate

TOTAL 673,087,220 596,987,621 433,440,276 496,989,570 557,488,757 100.00 6.71Top 10 617,755,989 536,525,823 395,309,603 436,398,046 482,054,303 91.78 7.99Others 55,331,231 60,461,798 38,130,673 60,591,524 75,434,454 8.22 -1.67

1 U.S.A. (Excl. Hawaii & Alaska) 228,176,249 182,089,469 150,097,620 136,927,589 215,161,324 33.90 4.972 Netherlands 221,991,519 196,562,258 116,913,944 174,804,631 147,321,120 32.98 16.653 Malaysia 47,098,760 44,755,457 28,419,536 41,651,305 32,051,476 7.00 15.234 Japan 40,438,146 27,488,727 20,094,269 12,085,845 21,925,563 6.01 26.325 Korea, Rep. Of (South) 21,804,249 7,009,487 6,357,835 11,790,126 6,044,534 3.24 67.576 Singapore 15,725,597 2,343,265 14,014,844 5,506,737 4,346,264 2.34 167.267 Italy 14,855,509 15,671,798 14,735,589 8,781,245 11,577,508 2.21 11.208 France 12,228,627 13,258,197 13,044,528 11,626,732 12,588,121 1.82 -0.399 China, People'S Rep. Of 9,834,601 32,042,913 16,061,196 18,115,097 17,022,275 1.46 6.32

10 Denmark 5,602,732 15,304,252 15,570,242 15,108,739 14,016,118 0.83 -13.5611 Taiwan 5,183,156 5,058,392 2,286,672 7,522,936 5,025,665 0.77 25.9412 Indonesia (Includes West Irian) 4,888,711 14,121,484 2,826,370 10,148,015 16,727,817 0.73 55.6913 Canada 4,639,683 3,111,893 4,943,589 5,313,322 4,100,614 0.69 8.6614 Spain 4,474,221 5,569,515 4,091,002 5,434,778 4,855,976 0.66 0.9215 Australia 4,372,813 2,881,300 2,665,768 4,634,001 5,386,420 0.65 0.8516 Great Britain And Northern Ireland 3,926,552 3,755,517 4,803,329 6,401,920 17,065,749 0.58 -26.1817 Belgium 3,413,876 2,042,183 1,450,759 2,432,973 2,009,918 0.51 22.1518 Germany 3,348,478 6,548,566 1,340,375 2,163,809 2,491,264 0.50 72.1219 Russian Federation (U.S.S.R.) 3,183,521 1,639,899 1,094,050 288,878 0 0.47 105.6920 Thailand 3,143,174 3,667,531 2,049,883 1,405,344 1,911,080 0.47 21.0021 Hong Kong S.A.R. 2,867,157 1,006,231 2,049,374 3,814,266 4,171,498 0.43 19.8022 Mexico 2,341,323 1,976,664 1,895,247 1,613,900 2,701,029 0.35 -0.0223 Chile 1,826,778 1,549,053 1,508,414 1,712,709 1,857,866 0.27 0.2224 Brazil 1,101,492 1,089,049 1,321,988 733,421 1,025,046 0.16 8.8325 Argentina 949,412 530,500 232,959 199,984 177,813 0.14 58.9126 Colombia 918,306 290,215 0 6,188 0 0.14 29.1127 New Zealand (Excludes Western Samo 762,615 1,799,584 1,634,849 1,647,864 1,750,954 0.11 -13.5628 Israel 706,412 620,616 207,375 152,106 82,888 0.10 83.2429 Ireland 466,154 382,340 556,004 281,337 1,014,128 0.07 4.0130 Greece 370,840 5,610 0 158 173 0.06 1,600.4231 India 353,611 118,081 113,374 1,666,329 658,794 0.05 65.8432 Norway 266,935 203,684 3,858 5,280 0 0.04 1,295.9133 Hungary 151,484 0 89,343 78,900 148,125 0.02 -33.3734 Poland 147,076 630 0 0 128,944 0.02 5,786.3535 Vietnam 141,877 44,013 27,736 743 3,885 0.02 958.2836 Uruguay 139,183 26,600 0 25,214 0 0.02 80.8137 Cuba 126,773 0 205,600 0 0 0.02 -25.0038 South Africa Rep. Of 118,956 27,023 16,650 12,223 10,762 0.02 113.0739 Romania 113,832 0 0 0 0 0.02 0.0040 Venezuela 109,443 96,836 36,000 127,959 123,681 0.02 28.4041 Portugal 70,075 173,930 0 127,229 0 0.01 -14.9342 Egypt 67,043 8,200 0 0 223,959 0.01 154.4043 Dominican Republic 56,448 0 0 0 0 0.01 0.0044 Turkey 55,310 21,750 9,000 9,198 10,783 0.01 69.7845 Iran 53,957 0 8,050 6,325 0 0.01 -18.1846 Netherlands Antilles 48,920 0 41,600 0 0 0.01 -25.0047 United Arab Emirates 47,422 17,103 6,056 314,548 254,684 0.01 71.2848 Switzerland 46,920 14,660 292 17,978 135 0.01 4,564.8249 Brunei Darussalam 40,160 11,160 2,132 1,596 640 0.01 216.5750 Saudi Arabia 35,900 57,696 16,756 99,591 85,224 0.01 35.0651 Mauritius 32,000 63,304 94,347 0 46,568 0.00 -45.5952 Myanmar (Burma) 29,280 0 136,800 0 0 0.00 -25.0053 Pakistan, Islamic Rep. 26,059 36,411 20,719 559,828 106,659 0.00 93.9754 El Salvador 26,000 66,200 82,400 44,582 13,023 0.00 61.6955 Sao Tome And Principe, Dem. Rep. Of 24,919 0 0 0 0 0.00 0.0056 Bangladesh 20,450 0 0 9,913 75,900 0.00 -46.7357 Hawaii 20,392 30,976 26,884 19,548 27,458 0.00 -2.5658 Peru 16,600 20,670 11,540 8,300 0 0.00 24.6259 Trust Territory Of The Pacific Islands 13,775 6,489 10,163 36,961 58,608 0.00 -8.33


- 72 -


- 73 -

ANNEX XI

DIRECTORY OF THE PHILIPPINE CHAMBER OF THE PHARMACEUTICAL INDUSTRY, INC. Member Company Tel. No./s Fax No.

1 ACCORD BIOLAB 936-3498 9363498 NO. 54 BELEN STREET, SAN BARTOLOME 936-3476 379-4691 NOVALICHES, QUEZON CITY

2 ACE PHARMACEUTICALS, INC. 931-0540 427-2577 101 DON VICENTE ST., DON ANTONIO HGTS 044-694-0718 931-0580 QUEZON CITY 951-3601 [email protected]

3 AD-DRUGSTEL 4537597 9207366 75 TANDANG SORA AVE. QUEZON CITY 92073 66

4 ALDRTZ 034-432-3270 034-432-3270 MAIN: 23 ALIJIS MORCIA ROAD BACOLOD CITY MLA. OFFICE: NO. 18 SALARY STREET 928-7761 928-7761 GSIS VILLAGE, PROJ. 8., QUEZON CITY

5 ALMAN PHARMACEUTICALS, INC. MLA. OFF: UNIT 1A PATRICIA BLDG. 853-1005/851-4608 845-5356 1050 EDSA, MAGALLANES VILL. MAKATI CITY 851-4690

6 ALPHAMED PHARMA CORP 413-3707 413-3707 409 SAN FRANCISCO DEL MONTE QUEZON CITY [email protected]

7 AM-EUROPHARMA CORPORATION 823-6232 KM 16 WEST SERVICE ROAD 822-1691 PARAÑAQUE CITY 842-4870 [email protected]

8 AMYLUM ENTERPRISES, INC. 723-6609 TO 11 723-6611 131 N DOMINGO STREET, SAN JUAN METRO MANILA [email protected]

9 ASIAN ANTIBIOTICS, INC. 634-0912 6340881 130 PIONEER STREET 634-0882 MANDALUYONG CITY

10 BASIC PHARMACEUTICAL CORP. 724-0647 OR 2931 7234151 38 BARASOAIN, LITTLE BAGUIO 723-9942 723-9942 SAN JUAN,M.M. 7234159 [email protected]


- 74 -

11 BIO FEMME, INC. 723 0442 TO 43 724 3856

2/F BUENAVENTURE PLAZA ORTIGAS AVENUE, SAN JUAN, M.M.

12 BIOLINK PHARMA 413-5079 413-5079

U - 1207 PRES. TOWER CONDO, TIMOG AVENUE 411-4448

QUEZON CITY [email protected]

13 BIO MEDIS, INC. 631 8501 7530 SHAW BOULEVARD MANDALUYONG CITY

14 BIO-STRATA PHARMACEUTICALS, INC. 631-6726 631-6726 101 SHAW BOULEVARD 632-0265 PASIG CITY [email protected]

15 BLOOMING FIELDS PHILS.,INC. 722-4637 7224915 6TH FLOOR TEXTRON BLDG. 168 LUNA MENCIAS ST., SAN JUAN, M.M. 7442065 [email protected]

16 CISTRON PHILS., INC. 807-4291 807-4247 19 VICENTE RECTO STREET PARANAQUE, M.M.

17 COMPACT PHARMACEUTICAL CORPORATION 294-6035 36 TANGKE STREE, MALINTA 291-2538 VALENZUELA CITY

18 DANLEX RESEARCH LABORATORIES 855-8233 855-8027 701 BAYVIEW INTERNATIONA TOWER II & III 855-8221 ROXAS BOULEVARD, PARANAQUE CITY

19 DIAMOND LABORATORIES, INC. 932-7555 932-7551 8 PERIA ROAD 931-1843 931-1826 COMMONWEALTH AVENUE 931-1179 932-9539 DILIMAN. QUEZON CITY 931-1838

http://diamondlabs.com/home.html [email protected]

20 DRUGMAKERS BIOTECH RESEARCH LABS., INC. 771-1086 771-0131

E & E INDUSTRIAL COMPLEX NARRA ROAD, BRGY. SAN ANTONIO 7710138 7710148 SAN PEDRO, LAGUNA [email protected]


- 75 -

21 ELIN PHARMACEUTICALS, INC. 633-7185 TO 86 6337189

10/F JMT CORPORATE CONDOMINIUM ADV AVENUE, ORTIGAS CENTER, PASIG CITY WAREHOUSE [email protected] 929-5367

22 E.L. LABORATORIES, INC. 049-541-3222 109 NORTH MAIN AVE., LAGUNA TECHNOPARK 049-541-3222 BIÑAN, LAGUNA MLA. 633-71 85 TO 87 633-7189 [email protected]

23 EUROHEALTH CARE EXPONENT, INC. 3733966 3730585 67 SCOUT FUENTEBELLA 3733922 QUEZON CITY [email protected]

24 FILADAMS PHARMA, INC. 922-2284 TO 88 921-0868 37 MAPAGKUMBABA COR. MATIPID ST. SIKATUNA VILLAGE, QUEZON CITY [email protected]

25 GENERAL DRUG & CHEM'L. CO., INC. 631-85.01 631-6021 82 MAYFLOWER STREET LOC 8808 MANDALUYONG CITY [email protected]

26 GERGREG PHARMACEUTICAL CORPORATION 687-0706 687-0875 SUITE 1708 ANTEL GLOBAL CORP CTR 6874122 J. VARGAS AVENUE, ORTIGAS CENTER PASIG CITY [email protected]

27 GX INTERNATIONAL, INC. 842-7155 TO 58 842-0376 8/F ALPAP II BLDG. TRADE ST. 7724452 COR INVESTMENT DRIVE MADRIGAL BUSINESS PARK, AYALA ALABANG, MUNTINLUPA, M.M.

www.gxionline.com [email protected]

28 HIZON LABORATORIES, INC. 697-5933 697-5937

MKTG OFFICE:

HIZON BLDG, 29 QUEZON AVE., QUEZON CITY

PLANT: ASSUMPTION ROAD SUMULONG HIGHWAY, ANTIPOLO CITY [email protected]

29 IAE PHARMACEUTICALS CORP. 711-6116 TO 17 741-3367 25 KABIGNAYAN STREET MEAR BANAWE LOC 24 & 27 QUEZON CITY 741-3366


- 76 -

30 INTEGRATED PHARMA., INC. 241-8501 to 04 241-3846

416 DASMARINAS STREET BINONDO. MANILA

www.integrated.com.ph [email protected]

31 JB ORCHIDS PHARMA, INC. 915-7242

CASILI, COMPOSTELA, CEBU 032-346-6399 912-0335 [email protected]

32 KAMIRE, INC. 718-1188 TO 90 7182535 429-C 2/F MIRANDA BLDG. SHAW BOULEVARD MANDALUYONG CITY

33 LARGEN MED, INC. 373-7054 373-7050 UNIT 202-203 METRO SQUARE BLDG. 373-7050 35 SCT. DE GUIA COR SCT. TUAZON STS. 373-7520

BRGY. LAGING HANDA, QUEZON CITY [email protected]

34 LEMA PHARMACEUTICALS, INC. 032-255-5144 032-253-0181

ROOM 201 MENCHAVEZ BLDG. 032-253-0181 ESCARIO ST., CEBU CITY [email protected]

35 LEWISON PHARMA 912-8511 912-8511 88 TERESA BUILDING, 15TH AVENUE 912-0053 CUBAO, QUEZON CITY 912-6997

36 LLOYD LABORATORIES, INC. 411 5860 376 22 86 CORPORATE OFFICE: 73 SCOUT FERNANDEZ STREET 372-3984 QUEZON CITY MFG. COMPLEX 044-7940159 044-794-0499 10 LLOYD AVE., 1ST BULACAN INDUSTRIAL CITY BO. TIKAY, MALOLOS , BULACAN [email protected] www.lloydlab.com/stats/

37 LR IMPERIAL PHARMACEUTICALS 7244086 7239604 2/F BONAVENTURE PLAZA ORTIGAS AVENEUE, WUEZON CITY

38 LVP PHILIPPINES

39 MACROPHARMA CORPORATION 634-8790 637-7596 SUITE 3204-B, TEKTITE EAST TOWER 634-8783 PHILIPPINES STOCK EXCHANGE CENTER 632-9070 ORTIGAS CENTER, PASIG CITY


- 77 -

40 MAXWELL BYRD SPECIALTY PHARMACEUTICALS & 687-3529 687-3375

PRODUCTS CORP. 687-3006 UNIT E -510, 5/F EAST TOWER, PSE BLDG. PSE CENTRE, EXCHANGE ROAD ORTIGAS CENTER, PASIG CITY [email protected]

41 MEDHAUS PHARMA, INC. 414 8318 4148318 139 K 1ST STREET KAMUNING, QUEZON CITY

42 MEDICHEM PHARMACEUTICALS, INC. 8152801 6/F DYNA VISION BUILDING 108 RADA STREET, LEGASPI VILLAGE MAKATI CITY

43 MEDIC AID DISTRIBUTORS, INC. 723-0071 TO 76 724-8639

202 ELCO BUILDING, E. RODRIGUEZ AVENUE LOC.120to122

QUEZON CITY 410-3250

44 MEDI-RX, INC. 920-7952 927-7747 MINDANAO AVENUE 453-0253 QUZON CITY 426-9754

45 MEDISYS DISTRIBUTORS 713-4983 713-4983 4628 EE VALENZUELA STREET 714-1764 STA. MESA, MANILA 716-3371

46 MERCURY DRUG CORPORATION 911-5071 TO 87 911-6673

7 MERCURY AVENUE COR. E. R ODRIGUEZ JR. 911-6654

AVENUE, BAGUMBAYAN, QUEZON CITY www.mercurydrug.com [email protected]

47 METROPOLITAN PHARMACEUTICAL PRODUCTS, INC. 8072782 807-2113

2/F MENESES HOLDINGS BLDG. 807-9756 G. PUYAT COR. C. ARAGON STS. BF HOMES, SUCAT, PARANAQUE, M.M.

[email protected] www.metropolitanpharma.com

48 MEYERS PHARMACEUTICALS (PHILS), INC. 372-6036 372-6028

176 ROOSEVELT AVENUE 372-6039 SAN JOSE DEL MONTE, QUEZON CITY [email protected]

49 MICEL MARKETING 364-7764 364-8763 156 AZUCENA STREET, 10TH AVENUE GRACE PARK, CALOOCAN CITY


- 78 -

50 MT. SINAI SCIENTIFIC & PHARMACEUTICAL SUPPLY 912-2123 912-2119

CARILLO-SANSANO BLDG. 912-2117 47-A ANNAPOLIS ST. CUBAO, Q.C. faithllerena2yahoo.com

51 NEW SMART FORMULAE TRADING CORP 374-6179 414-5014 ROOM 505 CEDAR BUILDING TIMOG AVENUE, QUEZON CITY

52 NOJO PHARMEDICS 929-0534 929-0534 20-A ENGINEERING STREET, GSIS VILLAGE 929-68-44 PROJECT 8, QUEZON CITY

53 NOVOMED, INC. 032-345-9147 032-3459147 PROV'L: 3/F DYZON BLDG. 032-422-5711 246 WIRELESS, MANDAUE CITY MLA: 566 SHAW BLVD., MANDALUYONG CITY novomed_island.com.ph

54 ONE PHARMA COMPANY, INC. 871-2941 to 43 872-4292 A. LIWANAG COR. G. DIAZ STS. 871-2537 871-7399 BFRV, CLASSI 1 LAS PINAS CITY

[email protected] www.onepharma.com.ph

55 ORO LABORATORIES, INC. 712-4969 712-3576

370 QUEZON AVENUE, QUEZON CITY 712-3556

56 PACIFIC PHARMACEUTICAL GENERICS, INC. 7431636 7431622 LAWYERS COOPERATIVE BLDG. 7113933 459 QUEZON AVENUE QUEZON CITY

57 PASCUAL LABORATORIES, INC. 044-693-1892 TO 95 044-693-1891 KM 31 MCARTHUR HIGHWAY 920-1911 to 15 4112622 BALAGTAS, BULACAN LOC 123

58 PEDIAPHARMA 4142989 4142987 PENTHOUSE 4, LANSDALE TOWER CONDO 86 MOTHER IGNACIA AVENUE QUEZON CITY

59 PEDIATRICA, INC. 725 6263 724 8616 3RD FLOOR BONAVENTURE PLAZA ORTIGAS AVENUE, SAN JUAN, M.M.


- 79 -

60 PASTEUR PHARMA 781-1447 781-1979

RM302 SGS FOUNDATION BLDG. 781-5835 1335 G. ARANETA AVENUE, SMH 731-4875 QUEZON CITY 740-7604 [email protected]

61 PHARMA DYNAMIC, INC. 532-2021 TO 23 532-2024 PDI BUILDING, 71 MAYSILO STREET 534-8241 MANDALUYONG CITY www.pharmadynamic.com.ph [email protected]

62 PHARMASAN, INC. 947-4522 934-7615 6 AGATHA ST., STA. TERESITA VILLAGE 934-7615 MARIKINA CITY

63 PHARMASPEC N.A., INC. 743-2880 743-7602 3RD FLOOR, HIZON BUILDING 29 QUEZON AVE., QUEZON CITY

64 PHARMATECHNICA LABORATORY, INC. 371-8090 371-0247 5 MORQUECILLO ST., SAN JOSE DEL MONTE 371-0247 to 48 QUEZON CITY PLANT: CAGAYAN VALLEY ROAD STO. CRISTO, PULITAN, BULACAN

65 PHILMED 942-3581 942-3580 LADISLAO DIWA STREET MARIKINA HEIGHTS, MARINA CITY

66 PHILIPPINE HEALTH FOOD MFG. CORP (049)5412391 (049)5412390 STA.ROSA BUSSINES PARK BARANGAY DON JOSE, STA. ROSA LAGUNA [email protected] DL746-8893

67 PHILIPPINE MEDICAL DENTAL SPECIALTIES 733-4221 733-3848 425 P. GOMEZ STREET QUIAPO, MANILA

68 PROHEALTH PHARMA PHILS.,INC. 637-6971 to 72 637-6963 2603, 26/F EAST TOWER 637-4907 PHIL. STOCK EXCHANGE CENTER ORTIGAS CENTER, PASIG CITY 1600

[email protected]/ http://www.prohealth.com.ph

69 PROSEL PHARMACEUTICALS, INC. 886-65-95 886-65-95 LOC.

26B CHATHAM HOUSE CONDOMINIUM 807 RUFINO COR VALERO STS. SALCEDO VILLAGE, MAKATI CITY [email protected]


- 80 -

70 QUALIPHARMA LABORATORIES 532-1690 532-1691

MRD BLDG. 870 KASIPAGAN STREET PLAINVIEW SUBDIVISION MANDALUYONG CITY

71 RANDRIL INTERNATIONAL CO., INC. 372-6637 to 39 372-6639 SUITE 401 4/F CEDAR EXECUTIVE BLDG. loc19 26 TIMOG AVE. COR SCOUT TOBIAS ST. QUEZON CITY www.ranbaxy.com [email protected]

72 RX CONSULTANTS, INC. 687-1472 687-1471 UNIT 809 PRESTIGE TOWER CONDOMINIUM 687-1471 EMERAL AVENUE, ORTIGAS CENTER PASIG CITY [email protected]

73 SIGART PHARMA CORP 371-4401 371-7430 ROOM 316 - 318 JIAO BLDG NO. 2 TIMOG AVENUE COR. QUEZON AVE. QUEZON CITY [email protected]

74 SCHEELE LABORATORIES PHILIPPINES, INC. 983-7229 2935197 7-8 LOPE DE GUZMAN STREET 983-4036 DALANDANAN, VALENZUELA CITY

75 SPLASH CORPORATION 984-5555 453-1754 3/F HBC CORPORATE CENTER NO. 548 MINDANAO AVENUE CORNER QUIRINO HIWAY, QUEZON CITY

76 SQUARE PHARMACEUTICALS, INC. 824-5228 824-5228 3428 EAST SERVICE ROAD, UNITED 2 824-5302 PARAÑAQUE CITY [email protected]

77 S.V. MORE PHARMA CORPORATION (M.M.L.) 373-6240 NO. 16 SCOUT TUAZON CORNER 373-6242 375-1721 ROCES AVE., QUEZON CITY [email protected] 373-6591

78 SVP PHILIPPINES


- 81 -

79 SYDENHAM LABORATORIES, INC. 533-9329 533-9219

566 SHAW BLVD. MANDALUYONG CITY 533-9740 PLANT:

AGUINALDO HIWAY NR. GOVERNOR'S DRIVE (046)-4165070 TO 72 (46)416-4680

DASMARINAS, CAVITE [email protected]

80 SYNCARE PHARMA 821-09 11 623 JOHNGLEN ST. MOONWALK PHASE 2 PARANAQUE CITY 1700

81 SWISS PHARMA RESEARCH LAB. 241-8501to 04 241-3846 416 DASMARINAS ST., BINONDO, MANILA 241-8501 loc113 PLANT: BARRIO PITTLAND 049-549-2372 or 73 049-549-7210 CABUYAO, LAGUNA 67001511 67001510 www.sprli.com [email protected]

82 TECHNOMED INTERNATIONAL, INC. 744-8646 721-1850 4/F MEDECOR BLDG., ORTTIGAS AVENUE 721-1320 GREENHILLS, SAN JUAN , M.M. 721-1860 [email protected]

83 THERAPHARMA, INC. 7264091 TO 95 725 0987 3/F BONAVENTURE PLAZA ORTIGAS AVE+B65, SAN JUAN METRO MANILA

84 TYNOR DRUG HOUSE, INC. 807-2123 TO 25 807-2111 MENESES HOLDINGS BLDG. G. PUYAT COR. C. ARAGON STREETS

BF COMM'L CENTER, SUCAT PARANAQUE,M.M. [email protected]

85 UNITED AMERICAN PHARMACEUTICALS 6318501

7530 SHAW BOULEVARD MANDALUYONG CITY

86 UNITED LABORATORIES, INC. 631-8501 746-8892 66 UNITED STREET LOC 5026 MANDALUYONG CITY www.unilab.com.ph

87 VENUTEK MEDICA, INC. 631-1554 636-3560 3/F DISPOPHIL BLDG. 631-1518 BLESSED JOSE MARIA ESCRIVA STREET ORTIGAS CENTER, PASIG CITY [email protected]


- 82 -

88 VERHEILEN PHARMACEUTICALS, INC. 636-3211 635-3082

1212 12TH FLOOR WEST TEKTITE TOWER 365-3082 PSE CENTER, ORTIGAS CENTER, PASIG CITY 912-2725 [email protected]

89 VINCELEE PHARMA 932-9483 932-9483 2211 COMMONWEALTH AVENUE QUEZON CITY

90 VIRGO PHARMACEUTICAL, INC. 740-1384 741-5903 MLA OFFICE . 270 N.S. AMORANTO AVE. 740-1385 STA . MESA HEIGHTS, QUEZON CITY PLANT: SANDICO ST., ABANGAN SUR 044-711-0406 MARILAO, BULACAN [email protected]

91 VITALINK PHARMA 926 68 09 920 4447 103 SCOUT DE GUIA STREET QUEZON CITY

92 WYCE PHARMA PHILIPPINES 411-0511 410-3680 UNIT A, 2ND FLOOR JACINTO BUILDING

QUEZON AVE. COR SCT. REYES, QUEZON CITY

[email protected]

93 YSS LABORATORIES COMPANY, INC. 524-0061 TO 63 524-0592 1133 UNITED NATIONS AVENUE 524-0349 PACO, MANILA [email protected] 8925936

94 ZENAUST PHARMACEUTICALS, INC. 746-0105 634-4327 67 WEST CAPITOL DRIVE PASIG CITY

95 ALSTAR CHEMIE SALES (PHILIPPINES) 809-1371 809-1370 U-A JEMP BUILDING, CABARRUS STREET 770-8141 BF HOMES, PARAÑAQUE CITY

96 ASHFORD PHARMA

97 ARCHIELION MEDICAL DISTRIBUTOR CENTER

98 BATON ROUGE LABORATORY 913-8732 926-69-85 GATE 40, ROAD 13, PAG-ASA 439-4320 QUEZON CITY


- 83 -

99 BOIE, INCORPORATED 8077695 7725102

520 ALABANG-ZAPOTE ROAD 8079675 ALMANZA,REAL STREET 8076303 LAS PINAS,M.M. 8079735 [email protected]

100 CORBRIDGE GROUP PHILIPPINES, INC. 448-7933 4487932 5TH FLOOR, JAFER BUILDING 118 WEST AVENUE, QUEZON CITY

101 ECE MARKETING 741-9058 741-9058 150 5TH A STREET, ECOLAND P-7 MATINA, DAVAO CITY

102 EURASIA RESEARCH PHARMA CORPORATION 852-2753 854-3486 PROVINCIAL OFF: SAN LEONARDO NUEVA ECIJA MLA. OFFICE: 776 APELO CRUZ STREET MALIBAY, PASAY CITY

102 GSA INTERPHARMA 425-1622 455-7254 NO. 2 DELOS REYES STREET CORNER ROAD 20, PROJECT 8 QUEZON CITY

103 JM TOLLMAN LABORATORIES, INC. 932-3266 932-3267 95 ZUZUARREGUI STREET, DILIMAN 932-3267 QUEZON CITY

104 LA FAYETTE PHARMACEUTICAL LABORATORIES 913-3723 913-3723

NO. 132 13TH AVENUE, CUBAO 437-5139 QUEZON CITY

105 LA CROESUS PHARMA, INC. 911-4151 911-2621 56 20TH AVENUE, CUBAO 049-572-7175 QUEZON CITY

106 LEJAL LABORATORIES, INC. 044-840-1333 044-935-3738 KM 18 MC ARTHUR HIGHWAY 044-935-3738 MEYCAUAYAN, BULACAN 044-8406053 373-3455

107 LUMAR PHARMA LAB. 926-8108 926-8249 MLA. 905 EDSA, QUEZON CITY 926-8249 PLANT: 5 FIRST BULACAN INDUSTRIAL CITY BRGY. TIKAY, MALOLOS, BULACAN (044)794-3758 TO 59

108 MAKATI MED 815-9911 LOC 7147 LOC 7002


- 84 -

109 MEDECIA MED, INC. (045) 963-4698 (045) 322-0846

MOLAVE STREET, AGUAS SUBDIVISION MANIBAAG, PORAK PAMPANGGA

110 MEDGEN LABORATORIES, INC. 456-0826 920-0306 72 MINDANAO AVENUE 456-0827 QUEZON CITY [email protected]

111 METZ PHARMA 920 7459 924 6701 27 SCOUT BAYORAN ST. LOC 106 QUEZON CITY

112 MORISHITA-SEGGS PHARMACEUTICALS, INC. 532-0443/9263 532-0740 782 SAN RAFAELSTREET 532-0740/2148 044-6415285 MANDALUYONG CITY 5320443

113 MYREX ETHICA LABORATORIES 744-0662 744-2560 140PANCHO VILLA STREET 724-0845 SAN JUAN 7250410

114 ORBIMJAY PHARMA 931-8024 931-8041 16 MT. RAINER STREET FILIINVEST 1, QUEZON CITY

115 PHILIPPINE MEDICAL DENTAL SPECIALTIES 733-4221 733-3848 425 P. GOMEZ STREET QUIAPO, MANILA PHILIPPINE PHARMAWEALTH, INC. 683-0053 TO 57 633-9512/13

116 SUITE 3001, 30/F TEKTITE EAST TOWER PSE BLDG., ORTIGAS CENTER, PASIG CITY

117 SCR TRADERS 032-2557877 032-2538659 898 GOVERNOR ROA STREET 032-2539375 CAPITOL SITE, CEBU CITY

118 SYNCARE PHARMA 821 0911 821 0911 623 JOHN GLEN STREET MOONWALK PHASE II, PARANAQUE CITY

119 ZYLAN PHARMA, INC. 823-5662, 823-1104 823-1104 33 GERMANY STREET 824-4647 BETTERLIVING SUBD. PARANAQUE CITY [email protected]

110 BLUE SKY (SWISS PHARMA GROUP) 2418501 Loc 106


- 85 -

ANNEX XII

DIRECTORY OF THE PHARMACEUTICAL AND HEALTHCARE ASSOCIATION OF THE PHILIPPINES Member Company Tel. No./s Telefax/Fax No.

1 ABBOTT LABORATORIES, INC. 631-8472 to 87 (632) 631-8488 / 634-0041 102 Edsa Mandaluyong, M.M. P.O. Box MCPO, 1229 Makati City

2 ALCON LABORATORIES (PHILS), INC. 721-3956 to 59 (632) 722-4167 3rd Flr., LGI Bldg., Ortigas Avenue Greenhills, San Juan, Metro Manila

3 ALTANA PHARMA AG 811-2047 ; 811-2061 (632) 811-2065 5th Floor, King's Court Building I 2129 Chino Roces Ave., Makati City

4 ASTRAZENECA PHARMACEUTICALS 823-8169 (632) 824-1298 Km. 14 South Superhighway Cor. Edison Road Paranaque, Metro Manila P.O. Box 7689 DAPO Lock Box, Pasay City

5 AVENTIS PASTEUR 816-1709 to 16 (632) 815-2979 7th Floor Gammon House 110 Rada St., Legaspi Village, Makati City

6 AVENTIS PHARMA 638-1369 to 74 (632) 638-6907 12th Floor Orient Square Building Emerald Avenue,,Ortigas Center

7 BAXTER HEALTHCARE PHILS., INC. 637-5368 to 69 (632) 637-5367 19th/F Wynsum Corporate Plaza Emerald Avenue, Ortigas Center, Pasig

8 BAYER PHILIPPINES, INC. (049) 549-7375 / 450-7200 (049) 549-3064 / 450-5487 8020-A Cecilia Araneta-Yulo Ave. Canlubang Industrial Estate Calamba, Laguna 4028

9 BECTON DICKINSON PHILS., INC. 815-8981 (632) 815-6642 27th Floor PBCom Tower, 6795 Ayala Avenue cor. Herrera St., Makati City

10 BIOMERIEUX S.A. 810-2131/ 817-7741 (632) 812-0896 11th Flr., Pearlbank Centre 146 Valero St., Salcedo Village, Makati


- 86 -

11 BLUE SKY TRADING CO., INC. 241-8501 to 04 (632) 241-0621 / 241-3846

416 Dasmarinas St., Binondo, Manila P.O. Box 1819 Manila

12 BOEHRINGER INGELHEIM PHILS., INC. 867-0800 (632) 848-0506 23rd Flr., Citibank Towers, Villar corner Valero Sts., Salcedo Village, Makati City

13 BOIE-TAKEDA CHEMICALS, INC. 886-6954 to 61 (632) 886-6941 12th Floor, Sky Plaza Bldg., Oledan Square 6788 Ayala Avenue, Makati City P.O. Box 850 MCPO, 1299 Makati City

14 BRISTOL-MYERS SQUIBB PHILS 841-8181 (632) 816-7752 2309 Don Chino Roces, Makati City P.O. Box 1031, MCPO, Metro Manila

15 CALMOSEPTINE PHILS., INC. (032) 344-6535 ; 343-7048 (032) 420-2534 710 Del Pilar St. Guizo Mandaue City

16 CARDINAL HEALTH AUSTRALIA 401 PTY. 284-3756 (632) 284-3769 8/F Citiland Tower Shaw Boulevard cor. St. Francis Mandaluyong City

17 CROMA MEDIC INC. 817-8541 (632) 812-8581 Suite 203, Alegria Building 2299 Pasong Tamo, Makati City P.O. Box 1818, MCPO, 1268 Makati City

18 CYGNET PHARMACEUTICALS, INC. 404-0108 (632) 536-1411 5837 Zobel Roxas St., Makati City

19 DANLEX RESEARCH LAB., INC. 855-8026 / 855-8027 (632) 855-8057 Apt. 1604 Bayview International Tower III Roxas Blvd. cor. NAIA Road, Paranaque Metro Manila

20 DIETHELM PHILS., INC. (049) 512-4000 to 19 (049) 512-4040 Bgy. Mamplasan Biñan, Laguna

21 DUNCAN PHARMACEUTICALS 892-0761 to 72 (632) 810-9320+F257 2266 Chino Roces Avenue, Makati City

22 ELI LILLY PHILIPPINES, INC. 634-5646 / 634-5704 634-7334 18th Floor Robinson's Galleria Center Edsa cor. Ortigas Avenue, Q.C.


- 87 -

23 EURO-MED LABORATORIES, PHILS., INC. 524-0091 to 98 (Manila) (632) 526-0977

Room 201 PPL Bldg. U.N. Avenue Corner San Marcelino, Manila

24 FARMACIA ORO 712-3556 / 712-4969 / 712-5375 (632) 712-3576

370 Quezon Avenue, Quezon City P.O. Box 2350 Manila

25 FARMACIA RUBI,INC. 243-2635 (632) 243-2636 433-435 Quintin Paredes St. Binondo, Manila

26 FVA MEDICAL SPECIALTIES, INC. 893-2658 / 628-1214 / 628-1236 (632) 815-0751

307 Cityland Condominium III V.A. Rufino St., Legaspi Village Makati City

27 GLAXOSMITHKLINE PHILS. 892-0761 to 72 (632) 893-8019 2266 ChinoRoces Ave., Makati City P.O. Box 586 MCPO, 1299 Makati City

28 GLOBAL COMMERCIAL TRADING CORP. 687-5941 to 43 (632) 687-5944 Unit 2601, Antel-Global Corp. Center No. 3 Doña Julia Vargas Avenue Ortigas Center, Pasig City

29 HI-EISAI PHARMACEUTICALS, INC. 887-1047 (632) 887-5172 20/F, Multinational Bancorporation Centre, 6805 Ayala Avenue, Makati City

30 HEXAL PHILS., INC 840-0411 to 13 (632) 830-2252 Unit 1105 Pearlbak Center 146 Valero St., Salcedo Village, Makati

31 HIZON LABORATORIES, INC. (Quezon City) 712-5906 to 09 (632) 697-5937 / 711-3987

29 Quezon Avenue, Quezon City (Antipolo) 697-5933 to 34

32 IMS HEALTH PHILIPPINES, INC. 890-1111 (632) 899-4941 2nd Floor LRI Business Plaza 210 Nicanor Garcia St., Bel-Air Village Makati City

33 INTERPHIL LABORATORIES (049) 549-2346 to 49 (632) 817-2435 Canlubang Industrial Estate (632) 817-7533 Bo. Pittland, Laguna


- 88 -

34 JANSSEN PHARMACEUTICA 824-7901 (632) 776-9820

a division of Johnson & Johnson Edison Road, Barrio Ibayo 1700 Parañaque City

35 JOHNSON & JOHNSON MEDICAL 824-7901 (632) 824-1345 Edison Road, Boarrio Ibayo 1700 Parañaque City

36 LABORATOIRES FOURNIER PHILS., INC. 815-8271 / 815-4602 (632) 815-4613 36/F Unit 3603 PBCom Tower 6795 Ayala Avenue, Makati

37 LIETZ, INC. RUDOLF 819-0631 (632) 819-5769 142 Legaspi St. Legaspi Village, Makati City P.O. Box 2348 MCPO, 1263 Makati City

38 MARKETLINK INTERNATIONAL CORP. 638-1461 to 70 (632) 638-3232 4/F The Taipan Place Building Emerald Avenue, Ortigas Center Pasig City

39 MEDICOMM PACIFIC, INC. 637-8151 to 55 (632) 637-8156 2nd Floor Jollibee Plaza Building Emerald Avenue, Ortigas Center Pasig City

40 MERCK, SHARP & DOHME PHILS. 885-0700 to 29 885-0773 to 75 26th Floor Philamlife Tower 8767 Paseo de Roxas, Makati City

41 MERCURY DRUG CORPORATION 911-5071 to 87 (632) 911-6664 No. 7 Mercury Avenue cor. E. Rodriguez Bagumbayan, Quezon City P.O. Box 1847 Manila

42 METRO DRUG, INC. 837-2121 to 38/ 837-3043 to 52 (632) 837-3055/ 837-3044

Manalac Ave., Sta. Maria Industrial Estate Babumbayan, Bicutan, Taguig, M.M.

43 METRO PHARMA PHILS., INC. 637-1849 to 53 (632) 637-6053 600 Shaw Boulevard, Pasig City

44 MORISHITA-SEGGS PHARMACEUTICALS 532-0443 / 532-2148 / 531-9242 (632) 532-0740

782 San Rafael Street, Mandaluyong Metro Manila


- 89 -

45 NATRAPHARM 541-4372 / 541-4378 / 821-7382 (632) 821-7383

The Patriot Bldg., Km. 19 West Service Rd. South Luzon Expressway Sucat, Paranaque P.O. Box 1211 MCPO, Makati City

46 NOVARTIS HEALTHCARE PHILS. 815-9371 to 85 (632) 816-6439 5/F Asian Reinsurance Bldg., Salcedo cor. Gamboa, Legaspi Village, Makati

47 ONE PHARMA COMPANY, INC. 872-4292 / 871-2943 / 872-3971 (632) 871-2941

A. Liwanag corner G. Diaz St. BFRV, Las Pinas City

48 ORIENT EURO PHARMA PHILS., INC. 815-1209 to 12 / 813-0117 to 18 (632) 817-3159

6th Floor, SEDCO I Bldg., cor. Rada Legaspi St., Legaspi Village, Makati City

49 ORGANON PHILIPPINES 817-7638 (63-2) 817-5221 5/F Feliza Building, 108 V.A. Rufino St. Legaspi Village, Makati

50 OTSUKA PHARMACEUTICAL CO., INC. 844-9266 / 843-2208 (632) 843-5718 / 811-2279 2nd Flr., King's Court II Building 2129 Pasong Tamo cor. Dela Rosa St., Mkti.

51 PACIFIC PHARMACEUTICALS 711-3933/ 712-4921/ 712-4990 (632) 712-4921 / 743-1622

Rm. 303 Lawyers Cooperative Building 459 Quezon Avenue, Quezon City P.O. Box 1783, Manila

52 PANPHARMA-MEINZ PHARMACEUTICALS CORP. 404-2445 to 46 / 404-2433 (632) 525-7408

10th Flr., Ramon Magsaysay Center Roxas Blvd., Malate, Manila

53 PFIZER, INC. 888-6001 (632) 864-3708 23rd Floor Ayala Life - FGU Center 6811 Ayala Avenue, Makati City

54 PHARMALINK 845-7472 / 845-7383 (632) 894-1665 Zuellig Bldg., Sen. Gil Puyat Avenue POB 2587, 1265 Makati City


- 90 -

55 PHARMASIA-CUVEST, INC. 813-7555 / 813-7565 (632) 894-0288

3rd Flr. Montepino Bldg. Adelantado St. cor. Gamboa & Amorsolo Sts., Legaspi Village Makati City

56 PHILIPPINE RENAL CARE, INC. 633-7291 (632) 633-7298 2/F JMT Corporate Center, ADB Avenue Pasig City

57 PHILUSA CORPORATION 631-1731 to 39 (632) 631-1740 28 Shaw Blvd. cor. Pioneer St., Pasig City P.O. Box 2338 Manila

58 QUALIMED PHARMA, INC. 687-1174 (632) 635-9232 Unit 1001 Centerpoint Building Ortigas Center, Pasig City

59 ROCHE PHILIPPINES, INC. 893-4567 (632) 893-3030 2252 Pasong Tamo, Makati City

60 SANOFI-SYNTHELABO 840-3888 (632) 813-1676 3rd Floor, Feliza Bldg., 108 Herrera St. Legaspi Village, Makati City P.O. Box 1243 MCPO, 1252 Makati City

61 SCHERING PHILIPPINE CORP. 893-8352 (632) 893-1388 36th Flr. PBCom Tower 6795 Ayala Ave. cor. Herrera St. Makati City

62 SCHERING-PLOUGH CORP. 637-0594 to 97 / 638-2490 to 96 (632) 638-2497

12th Floor San Miguel Properties Centre St. Francis St., Ortigas Center Mandaluyong City

63 SCHWARZ PHARMA 894-2666 (632) 894-2630 2/F Annex 2 Zuellig Building Malugay St., Makati City

64 STIEFEL PHILS., INC. 638-0632 (632) 637-6875 1604 West Tower, PSE Center Ortigas Center, Pasig City


- 91 -

65 SWISS PHARMA RESEARCH LAB., INC. 241-8501 to 04 / (049) 549-2373

(049) 549-7210 / (049) 549-7774 to 77

Barrio Diezmo, Cabuyao Laguna (632) 241-0621 Mla. Office: 416 Dasmarinas St. Binondo Manila

66 TAISHO PHARMACEUTICALS PHILS., INC. 893-5747 / 817-1284 / 893-2895 (63-2) 812-4599

#51 Paseo de Roxas cor. Gil Puyat Avenue Makati City

67 TRANSFARMA PHILIPPINES, INC. 837-8663 (632) 837-3056 Metro Drug Building, Mañalac Avenue Bagumbayan, Taguig, Metro Manila

68 3M PHARMACEUTICALS 813-3781-89 (632) 814-5873 18/F PCI Bank Tower II Makati Avenue, Makati City

69 VENDIZ PHARMACEUTICALS, INC. 928-8079; 929-3169 (632) 929-4261 116 Esteban Abada St. Loyola Heights Quezon City

70 VIZCARRA PHARMA, INC. 523-3037 / 524-5641 to 42 (632) 522-3580 6th Floor Segundina Bldg. 464 United Nations Avenue Ermita, Manila

71 WELLCOME HEALTHCARE PHILS. 892-0761 to 72 (632) 893-8018 2266 Chino Roces Avenue Makati City

72 WYETH PHILIPPINES 843-0941 to 50 (632) 817-3523 2236 Chino Roces Ave., Makati City

73 YUNG SHIN (PHILIPPINES), INC. 896-7517 / 896-1586 (632) 896-7520 8822 Sampaloc St., San Antonio Village Makati City

74 ZUELLIG PHARMA CORP. 819-1561 / 816-1189 (632) 810-1204 Zuellig Bldg., Sen Gil Puyat Ave., Makati P.O. Box 2587, 1265 Manila


- 92 -


- 93 -

ANNEX XIII

ENTERPRISE/PRODUCT PROFILE FORMS


- 94 -

Name and Title: Isagani B. Ocampo – Operations Manager

Company name Ace Pharmaceuticals, Inc.

Street - POB 101 Don Vicente St., Kon Antonio Heights, Brg. Holy Spirit

City - Country Quezon City, Philippines Email: [email protected] Tel: 632.9310540 Fax: 632.4272577

Year established: 1975 Number of employees: 130 Bank Ref: BPI,PNB Website address of company:

Activities Please check ALL the present activities of your company

Exporter WholesalerRetailer Manufacturer

Producer Importer Trader Other:

Countries previously imported/exported to:

Description (please give generic names and specify if the product is indigenous) I* E* 1. Anaesthetics:

General anaesthetics & oxygen Local anaesthetics Preoperative medication and sedation

2. Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs)

NSAIMs Opioid analgesics Used to treat gout DMARDs

3. Antiallergics and medicines used in anaphylaxis 4. Antidotes and other substances used in poisoning:

Non-specific Specific

5. Anticonvulsants/antiepileptics: 6. Anti-infective medicines:

Anthelminthics Antibacterials Antifungal (oral)

Antiviral Antiprotozoal Insect repellents

7. Antimigraine medicines: For treatment of acute attack For prophylaxis

8. Antineoplastic, immunosuppressives and medicines used in palliative care:

Immunosuppressive Cytotoxic medicines

Hormones and antihormones Medicines used in palliative care

9. Antiparkinsonism medicines 10. Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation

11. Blood products and plasma substitutes:

Plasma substitutes Plasma fractions for specific use

12. Cardiovascular medicines:

Antianginal Antiarrhythmic Antihypertensive

Used in heart failure Antithrombotic Lipid-lowering

13. Dermatological medicines (topical)

Antifungal Anti-infective Anti-inflammatory/antipruritic

Astringent Skin differentiation/proliferation Scabicides/pediculicides

Ultraviolet

14. Diagnostic agents:

Ophthalmic Radiocontrast media

15. Disinfectants and antiseptics:

Antiseptics Disinfectants


- 95 -

16. Diuretics 17. Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxativs

Used in diarrhoea Antidiarrhoeal (symptomatic) 18. Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulins/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines

19. Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines

20. Muscle relaxants (peripherally acting) and cholinesterase inhibitors 21. Ophthalmological preparations: Anti-infective Anti-inflammatory Local anaesthetics Miotics and antiglaucoma Mydriatics

22. Oxytocics and antioxytocics: Oxytocics Antioxytocics

23. Petitoneal dialysis solution 24. Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders

25. Medicines acting on the respiratory tract 26. Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous

27. Vitamins and minerals 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, thizomes, leaves, fruits, seeds and (root)barks to be used in herbal medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Perfumery oils Preservatives Other additives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biothec 36. Natural medicines (formulated)

I* = Import, E* = Export


- 96 -

Name and Title: Limuel Z. Lazo

Company name Asian Antibiotics, Inc.

Street - POB 130 Pioneer St.

City - Country Mandaluyong City, Philippines Email: [email protected] Tel: 632.6318501/6340912/6340082 Fax: 6340881

Year established: 1998 Number of employees: 92 Bank Ref: Website address of company:




Countries previously imported/exported to: Europe, India, China,Italy, Germany, France























Ultraviolet






- 97 -











- 98 -

Name and Title: Teresita T. Chan

Company name Basic Pharmaceutical Corporation

Street - POB 38 Barasoin St., Little Baguio

City - Country San Juan, Metro Manila, Philippines Email: [email protected] Tel: 632.7329942/632.7234159 Fax: 632.7234151

Year established: 1991 Number of employees: 50 Bank Ref: BPI/Metrobank Website address of company: Basicpharma.mydestiny.net



























Ultraviolet






- 99 -











- 100 -

Name and Title: Sheila Mae M. Velilla- General Manager

Company name Biolink Pharma

Street - POB Unit 1207 President Tower, 81 Timog Avenue

City - Country Quezon City, Philippines Email:biolinkpharm@ pacific.net.ph Tel: 632.4114448/4135079 Fax: 632.4135079

Year established: Number of employees: 20 Bank Ref: Metrobank, UnionBank Website address of company: www.biolinkpharma.com



























Ultraviolet






- 101 -











- 102 -

Name and Title: Paulo P. Mamangun, Jr. - President

Company name Coconut Haven Philippines, Inc.

Street - POB C837 Turin, BF Homes, International

City - Country Las Piñas, Philippines Email: [email protected] Tel: 632.8267571 Fax: 632.8267571

Year established: 2003 Number of employees: 18 Bank Ref: Website address of company: www.coconuthaven.com




Countries previously imported/exported to: USA























Ultraviolet






- 103 -











- 104 -

Name and Title: Ma. Carlita R. Doran-President

Company name CRD Herbal Products

Street - POB Lot 29 Blk. 54 Braceville St., Fairmont Park II, North Fairview


Year established: Number of employees: 20 Bank Ref: Metrobank Website address of company:



























Ultraviolet






- 105 -











- 106 -

Name and Title: Marilou Buensuceso

Company name E.L. Laboratories, Inc.

Street - POB 109 North Main Ave., Laguna Technopark

City - Country Laguna, Philippines

Email: Tel: 6349.5413222/6337185 to 87 Fax: 6337189

Year established: 1997 Number of employees: 100 Bank Ref: DBP Website address of company:




Countries previously imported/exported to: Vietnam, Singapore























Ultraviolet






- 107 -











- 108 -

Name and Title: Virgilio V. Ecarma - Chief Executive Officer

Company name Ecarma Health Options

Street - POB 259 Doña Soledad Extension, Better Living Subd.,

City - Country Parañaque City, Philippines 1711

Email: [email protected] Tel: 632.8245175/632.8231480 Fax: 632.8227045

Year established: 1997 Number of employees: 25 Bank Ref: Equitable PCI Bank Website address of company: www.ecarma.net




Countries previously imported/exported to: Kenya, Uganda, Tanzania, Japan/USA, India























Ultraviolet






- 109 -











- 110 -

Name and Title: Marilou Buensuceso - President

Company name Elin Pharma, Inc.

Street - POB 10/F JMT Corporate Condominium, ADB Avenue, Ortigas Center

City - Country Pasig City, Philippines Email: [email protected] Tel: 632.6337185 to 86 Fax: 632.633.7189

Year established: 1969 Number of employees: 100 Bank Ref: BPI Website address of company:




Countries previously imported/exported to: India, Croatia, Spain, China























Ultraviolet






- 111 -











- 112 -

Name and Title: Gelacio C. Cruz - President

Company name Gergreg Pharmaceutical Corporation

Street - POB S1708 Antel Global Corporate Center, J. Vargas Ave., Ortigas Center

City - Country Pasig City, Philippines Email: [email protected] Tel: 632.6870706/6874122 Fax: 632.6870875

Year established: 1986 Number of employees: 60 Bank Ref: Metrobank Website address of company:



























Ultraviolet






- 113 -











- 114 -

Name and Title: Lucita Yu Soriano – Executive Director

Company name Hizon Laboratories, Inc.

Street - POB Assumption Road, Sumulong Highway

City - Country Antipolo City, Philippines Email: [email protected] Tel: 632.6975933 Fax: 632.6975937

Year established: 1898 Number of employees: 500+ Bank Ref: Website address of company:




Countries previously imported/exported to: Europe, China, India,Singapore























Ultraviolet






- 115 -











- 116 -

Name and Title: Daisylinda S. Garcia – General Manager

Company name Lafayette Pharmaceutical Laboratories, Inc.

Street - POB 132 13th Avenue, Cubao

City - Country Quezon City, Philippines Email: [email protected] Tel: 632.9133723/4375139 Fax: 632.9133723

Year established: 1995 Number of employees: 150+ Bank Ref: Website address of company: www.Lafayette.com.ph



























Ultraviolet






- 117 -











- 118 -

Name and Title: Nestor T. Mendoza – Business Development Manager

Company name Lloyd Laboratories, Inc.

Street - POB 73 Scout Fernandez St.,

City - Country Quezon City, Philippines

Email: [email protected] Tel: 632.4115860/3723984 Fax: 632.3762286

Year established: 1989 Number of employees: 264 Bank Ref: BPI Website address of company: www.lloydlab.com/stats




Countries previously imported/exported to: India, Singapore























Ultraviolet






- 119 -











- 120 -

Name and Title: Ma. Lourdes Jalandoon - Pharmacist

Company name Macropharma Corporation

Street - POB 3204 Tektite East Tower, Stock Exchange, Ortigas Center

City - Country Pasig City, Philippines


Year established: 1999 Number of employees: 13 Bank Ref: Website address of company: www.macropharma.com.ph




Countries previously imported/exported to: Korea























Ultraviolet






- 121 -











- 122 -

Name and Title: Evenson Uy Sian – General Manager

Company name Natural Quality Corporation

Street - POB No. 59 B.G. Belmonte St., 2F 88 Place, New Manila

City - Country Quezon City, Philippines

Email: [email protected] Tel: 632.7231828 Fax: 632.7231798

Year established: 2002 Number of employees: 5 Bank Ref: Metrobank Website address of company: www.natturaltm.com




Countries previously imported/exported to: Middle East, USA, Japan























Ultraviolet






- 123 -











- 124 -

Name and Title: Arturo L. Xavier

Company name Paren-Pharma,Inc

Street - POB G/F Agchem Bldg.,197 Doña Soledad Ave.,Ext.,Bicutan

City - Country Parañaque City,Philipiines Email: [email protected] Tel: 8225510 Fax: 632.821.5022

Year established: Number of employees: 7 Bank Ref: Metrobank Website address of company: Paren.org




Countries previously imported/exported to: India























Ultraviolet






- 125 -











- 126 -

Name and Title: Tess E. Santos - President

Company name Prosource International, Inc.

Street - POB Platinum 2000, 7 Annapolis, Greenhills

City - Country San Juan, Metro Manila, Philippines Email: [email protected] Tel: 632.7273768 Fax: 632.7273766

Year established: Number of employees: 12 Bank Ref: Asia United Bank Website address of company:




Countries previously imported/exported to: USA/USA, Singapore























Ultraviolet






- 127 -








27. Vitamins and minerals Grape Extract, Skin Table 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, thizomes, leaves, fruits, seeds and (root)barks to be used in herbal medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Perfumery oils Preservatives Other additives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biothec 36. Natural medicines (formulated)



- 128 -

Name and Title: Rommel dela Cruz - Vice President/Operations Manager

Company name RCC Amazing Touch International, Inc.

Street - POB 1-5 Teachers Bliss Condo 2, Balon Bato


Year established: Number of employees: 37 Bank Ref: BPI Website address of company: www.rccamazingtouch.com



























Ultraviolet






- 129 -








27. Vitamins and minerals 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, thizomes, leaves, fruits, seeds and (root)barks to be used in herbal medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Perfumery oils Preservatives Other additives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biothec 36. Natural medicines (formulated) Anti-Visral Herbal Cream preparations



- 130 -

Name and Title: Go, Thelma Tobias – General Manager

Company name Scheele Laboratories Phils., Inc.

Street - POB 7 Lope de Guzman St., Dalandanan

City - Country Valenzuela City, Philippines






Countries previously imported/exported to: Raw materials only China, HongKong,Singapore,Israel,Germany























Ultraviolet






- 131 -







25. Medicines acting on the respiratory tract 26. Solutions correcting water, electrolyte and acid-base disturbances:

Oral Parenteral Miscellaneous




- 132 -

Name and Title: Michael Francis A. Dela Cruz

Company name Sydenham Laboratories, Inc.

Street - POB E. Aguinaldo Hi-way corner Governors Drive

City - Country Dasmariñas Cavite, Philippines

Email: [email protected] Tel: 6346.4165070 to 72 Fax: 6346.4164680

Year established: 1975 Number of employees: 177 Bank Ref: Land Bank Website address of company:



























Ultraviolet






- 133 -











- 134 -

Name and Title: Tessa Castro /Div. VP – Regional Sourcing

Company name United Laboratories, Inc.

Street - POB 66 United St.

City - Country Mandaluyong City, Philippines Email: [email protected] Tel: 632.6318501 Fax: 632.6385828

Year established: 1945 Number of employees: 2000 Bank Ref: Website address of company: www.unilab.com.ph



























Ultraviolet






- 135 -











- 136 -

Name and Title: Racquel P. Villanueva – AVP Manufacturing Operations

Company name Virgo Pharmaceutical Laboratory

Street - POB 17 Hernani St., Sta. Mesa Heights

City - Country Quezon City, Philippines, Inc.

Email: [email protected] Tel: 632.7401384 Fax: 632.7415903

Year established: 1971 Number of employees: 80 Bank Ref: Metrobank Website address of company:




Countries previously imported/exported to: China, India, Singapore,Hong Kong, Spain,Bulgaria























Ultraviolet






- 137 -











- 138 -

Name and Title: Edward I. Isaac - CEO

Company name Verheilen Pharmaceuticals, Inc.

Street - POB 2204-C West Tektite Towers, Phil. Stock Exchange Center, Ortigas Center

City - Country Pasig City, Philippines Email: [email protected] Tel: 632.6353082/6323211 Fax: 632.6353082





Countries previously imported/exported to: Germany, Greece, Cyprus,India







5. Anticonvulsants/antiepileptics: 6. Anti-infective medicines: antibiotics (Clarithromycin,Ciprofloxacin)










12. Cardiovascular medicines: Atenolol



13. Dermatological medicines (topical) Anti-histamine (Cetirizine)



Ultraviolet






- 139 -

16. Diuretics 17. Gastrointestinal medicines: Anti-ulcers (Ranitidine, Omeprazole) Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxativs










- 140 -

Name and Title:

Company name

Street - POB

City - Country

Email: Tel: Fax:

Year established: Number of employees: Bank Ref: Website address of company:



























Ultraviolet






- 141 -










Final Report Philippines - Amazon S3s3.amazonaws.com/zanran_storage/ leading causes of morbidity,...

Documents

Transcript of Final Report Philippines - Amazon S3s3.amazonaws.com/zanran_storage/ leading causes of morbidity,...